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In order for the busy and crowded cell to have a semblance of organization, it leverages a 
complex and dynamic network of polymers, the cytoskeleton, to provide structure and serve as 
molecular roads for cargo transport. Two main polymer systems, microtubules and actin filaments, 
provide long- and short-range transport, respectively. Additionally, microtubules form the mitotic 
spindle and primary cilia, while actin filaments are critical for cell migration and muscle 
contraction. How cytoskeletal elements have such diverse functional roles is in part due to post-
translational modifications, where specific chemical modifications signal for protein interactions 
and particular motor protein motility. For example, tubulin methylation is only found on mitotic 
spindles, the microtubule-based bipolar structure that separates chromosomes during cell division 
and is enzymatically added by SETD2. SETD2 canonically modifies histones, specifically histone 
3 at lysine 36, and is the only enzyme that can tri-methylate this residue.  
Knock-out of SETD2 results in histone- and/or microtubule-dependent genetic instability 
leading to cancer-driving mitotic defects like multipolar spindles and micronuclei formation. 
Mutations in SETD2 are implicated in cancer, most commonly in the kidney cancer clear cell renal 
cell carcinoma (ccRCC), with SETD2 mutations occurring in 10-15% of all ccRCC cases. Thus 
far, the role of SETD2 in cancer has only been studied in a histone methylation context, but the 
contribution of cytoskeletal methylation remains unclear. Studies using tumor cells from ccRCC 
patients demonstrated that when the level of the SETD2 gene product is less than normal 
(haploinsufficiency), there is a loss of tubulin methylation and genomic instability, whereas total 
SETD2 inactivation results in a loss of histone methylation. This stepwise model for the loss of 
SETD2 functionality describes histone and tubulin methylation at the gene level but does not 
describe the enzymatic regulation of SETD2 amongst its substrates biochemically. Moreover, 
specific ccRCC mutations have a differential impact on either histone or tubulin methylation in 
cells, where a R2510H mutation, found in a domain important for regulating protein-protein 
interactions of SETD2 (the Set2 Rpb1 Interacting SRI domain), retains histone methylation but 
 
xiii 
not tubulin methylation. As such, there remains a significant realm of tubulin-dependent processes 
that drive ccRCC pathologies that remain unexplored.  
 In this study, I used in vitro biochemical reconstitution with recombinant proteins to 
determine how SETD2 recognizes and methylates tubulin in addition to actin. By exploiting 
known tubulin-targeting agents, I found that SETD2 preferentially methylates the dimeric form of 
tubulin over microtubule polymers and, using recombinant single-isotype tubulin, I demonstrated 
that methylation is restricted to lysine 40 of alpha-tubulin. Moreover, by introducing pathogenic 
mutations into SETD2 to probe the recognition of histone and tubulin substrates, I found that 
particular mutations within the SRI domain tune histone and tubulin methylation by regulating 
protein-protein interactions with tubulin or RNA Polymerase II. Lastly, I found that tubulin 
substrate recognition requires the negatively-charged C-terminal tail of alpha-tubulin. Curiously, 
the SRI domain does not play a similar regulatory role with actin substrate suggesting an 
alternative recognition site, but our collaborative work found that actin methylation by SETD2 is 
necessary for cell motility and actin dynamics at the cell periphery. Future studies into tubulin and 
actin chemical modifications are required to understand the nuanced interactions and crosstalk 
amongst histone, tubulin, and actin chemical codes in cells and their implications for cancer and 





Chapter 1: Introduction 
1. 1 Cytoskeletal networks in cells 
Cellular processes are extremely diverse and complicated, yet essential for life. The wide 
range of tasks that each individual cell carries out, either in isolation or in collections of tissues 
and organisms, must be controlled and organized in such a way that processes occur at the correct 
time and in the right place. For many processes, random diffusion is insufficient to achieve 
coordination especially in the crowded and viscous cytoplasm (Fulton 1982; I. Yu et al. 2016). As 
Fig. 1.1 Two main cytoskeletal networks in cells, microtubules and actin filaments. 
Cartoon schematic showing left) a cell with a blue nucleus, dark green microtubules, and 
orange actin filaments, right top) microtubule made of green a-tubulin and blue b-tubulin 
heterodimers, with red dynein and yellow kinesin motors, right bottom) actin with purple 
myosin motor.  
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such, a complex dynamic network of protein polymers called the cytoskeleton facilitates this 
spatio-temporality. Cytoskeletal polymers exist within the cytoplasm of cells and extend from the 
cell nucleus to the cell membrane giving the cell its shape, thus “cyto-skeleton.” These polymer 
networks are critical for a myriad of cellular functions, including cell migration, cell signaling, cell 
division, and intracellular transport of vesicles and organelles. Additionally, they form critical 
structures within the cell like the mitotic spindle, flagella, and cilia. Even though cytoskeletal 
elements are more common in eukaryotic cells, bacteria and archaea have homologous proteins 
that also form polymers for cell structure and division.  
To facilitate a complex set of cellular behaviors, eukaryotic cells evolved two main 
networks, actin fibers and microtubules, that build the foundational framework of the cell. The 
first indication of these networks likely came from early microscopy studies by Walter Flemming 
in the mid 1800s. One of his illustrations shows what we now iconically understand to be the 
mitotic spindle, though the relationship between the “thick fibers” (chromosomes) and the “thin 
fibers” (microtubules) was not known at the time, and both were thought to be manifestations of 
nuclear structure as the cell was dividing (Flemming 1878). In the late 1800s, live cell imaging in 
diatoms led to the concept that the cytoplasm in living cells contained “spindle fibers” that had 
sporadic organization that could interact with the extracellular matrix (Lauterborn 1896). Though 
characterization of the cytoskeleton was underway, it wasn’t until about 50 years later that actin 
was identified during WWII in a Hungarian lab studying muscle contraction (Szent-Györgyi 
1942), and almost 70 years later that microtubules were imaged and given a name in a study of 
plant cells (Ledbetter and Porter 1963).  
Actin fibers and microtubules are both polarized cytoskeletal filaments built from smaller 
subunits, actin and tubulin, respectively. Both actin and tubulin are globular proteins. Actin 
monomer contains two domains, outer and inner, which both contain two subdomains resulting in 
flat rectangular-like shape (Dominguez and Holmes 2011). Tubulin is a heterodimer of a- and b-
tubulin which both contain a nucleotide binding pocket but only b-tubulin has catalytic 
hydrolyzing activity (Downing and Nogales 1998). The C-terminal end of all tubulins have a 
flexible tail that aligns along the outside of the microtubule in polymer form. Actin and tubulin 
disassembly and assembly into polymers depends on ATP- or GTPase activity of individual 
subunits, with the process of dynamic instability of polymer growing and shrinking important for 
many cellular processes as well (H. P. Erickson and O’Brien 1992; R. Li and Gundersen 2008). 
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For example, rapid depolymerization of the microtubules in a mitotic spindle is critical for 
chromosome segregation, and depolymerization of actin filaments is important for cell migration 
(Carlier et al. 1997; Petry 2016). Moreover, both of these networks have a polarity, where the 
slow-growing ends of microtubules and pointed ends of actin (minus ends) are directed towards 
the center of the cell, and the quick-growing ends of microtubules and barbed ends of actin (plus 
ends) are directed outwards towards the cell periphery (Fletcher and Mullins 2010). Cytoskeletal 
polarity helps orient cellular structures in addition to directing intracellular transport.  
Cytoskeletal functions depend on their inherent dynamics in addition to molecular motors 
that use the protein polymer networks as roads. There are three major types of motors: microtubule-
based kinesin and dynein, and actin-based myosin. Each of these motor proteins convert chemical 
energy from adenosine triphosphate (ATP) hydrolysis into mechanical energy to transport 
themselves and their cargos along their respective polymers (Knight and Molloy 1999; Vale and 
Milligan 2000). This ATP-ase activity is localized in a catalytic motor domain which is typically 
dimerized through a coil-coiled element which is flanked by a tail domain (Schliwa 1999; Veigel 
et al. 1999; Hancock and Howard 1998). As such, ATP hydrolysis and the subsequent mechanical 
output results in a “stepping” on cytoskeletal filaments and allows for intracellular transport. The 
motors themselves leverage the inherent polarity of the filaments, with kinesin and myosin motors 
walking towards the plus-ends of microtubules and actin fibers, respectively (Verhey and 
Hammond 2009; N. Hirokawa et al. 2009; Amanda Hartman and Spudich 2012), and dynein 
motors, along with some myosin motors, that walk towards the minus-ends of microtubules 
(Vallee, Shpetner, and Paschal 1989). Kinesin motors in eukaryotes are encoded by at least 45 KIF 
genes that are categorized into 15 superfamilies, called kinesin-1 to kinesin-14 (Nobutaka 
Hirokawa et al. 2009). Before the mid-2000s, kinesins were being named by diverse and 
inconsistent criteria, resulting in a revised nomenclature that keeps the individual names, but alters 
the classification scheme “to minimize confusion” resulting in non-intuitive schemas like KIF1A 
classified as a kinesin-3 motor, and KIF5A as a kinesin-1 motor (Lawrence et al. 2004). Most 
kinesins are involved in trafficking, but some of them have particular functions for example 
tethering mitotic spindles and chromosome segregation by KIF18A or anchoring by KIF7 (Mayr 
et al. 2007; Yue et al. 2018). Myosin motors for actin filament-based transport also have a complex 
phylogeny, with ~30 genes encoding myosin classified into 15 families (Sellers 2000). Dynein 
motors are much more straightforward as they only fall into two major subgroups, axonemal and 
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cytoplasmic, further broken down into seven classes (Höök and Vallee 2006). Cytoplasmic dynein-
1 is the motor responsible for most cellular trafficking and retrograde transport.  
1.2 Chemical codes direct cellular processes 
How motor proteins are accurately trafficked in cells is, in part, due to chemical 
modifications to tubulin and actin. Beyond the cytoskeleton, most proteins in the cell can have 
post translational modifications (PTM) which impacts cell signaling, degradation, and other 
cellular functions in general. These PTMs are covalent additions to proteins and increase the 
functional diversity of cytoskeletal elements. Sets of enzymes called writers, erasers, and readers 
add, remove, and recognize chemical modifications, respectively. The complex landscape of 
readers, writers, and erasers of chemical modifications depends on existing, yet dynamic, chemical 
modifications. 
 
1.2.1 Tubulin code 
Tubulin code comprises chemical modifications to tubulin proteins, but also a number of 
different isotypes. The concept of isotypes and modifications controlling microtubule function was 
proposed as early as the 1970s when genotyping identified a- and b-tubulin isotypes in different 
species and covalent modifications were first identified (Cavalier-Smith 1978; Ludueña 1998). 
However, due to the complexity of the system, the tubulin code resisted functional characterization 
for many years, until finally being named in the 2000s (Verhey and Gaertig 2007). 
Tubulin isotypes come from expression of alternative tubulin genes. The complexity and 
mysterious genetic evolution of tubulin genes is reflected in the confusing nomenclature, which 
makes them really fun to talk about at conferences (Khodiyar et al. 2007). Sequence alignments 
show that eukaryotic tubulin is highly conserved, but are extremely divergent from their 
prokaryotic relatives FtsZ, the most similarity within the GTP-ase domains rather than the 
protofilament interface (Harold P. Erickson 2007). Nevertheless, during tubulin evolution the 
number of isotypes varied across species and phyla, for example yeast have two a-tubulins and 
one b-tubuln (Schatz et al. 1986; Neff et al. 1983), whereas humans have eight genes for each. 
Surveying isotypes across organisms, it was observed that different tissues and cell types had 
different expression levels of particular isotypes. For example, a-tubulin isotypes in root, leaf, and 
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flower cells in plants have different expression levels, Drosophila a-tubulin isotypes can be male- 
or female-specific in sex cells, and in mice and chickens a-tubulin isotypes have varied expression 
in all cell types (Carpenter et al. 1992; Theurkauf et al. 1986; Panda et al. 1994). Despite the fact 
that expression is somewhat tissue-specific, not all isotypes are functionally distinct (Schatz, 
Georges, and Solomon 1987; Hoffman and Cleveland 1988; Bond et al. 1986). That said, some 
can have profound impact on cell function, in particular the b-tubulin isoforms. For example, 
expressing bTub3 in place of bTub2 in Drosophila testes resulted in the inability to form an 
axoneme or meiotic spindle (Hoyle and Raff 1990). Additionally, the loss of aTub1A is perinatal 
lethal and leads to forebrain dysmorphology (Bitterman et al. 2018) and the overexpression of 
bTub3 in non-brain cells correlates with cancer (Person et al. 2017).  
In addition to having different isotypes, tubulin can be subjected to a number of PTMs. 
Common tubulin-specific PTMs include phosphorylation, acetylation, methylation, and ribosome-
independent tyrosination, (poly)glutamylation, and (poly)glycylation. Moreover, removal of single 
Fig. 1.2 Tubulin code. Cartoon showing top) tubulin dimer with a-tubulin in green and b-
tubulin in blue. Each tubulin monomer has eight isotypes and a long C-terminal tail which is 
highly modified, and bottom) the most common chemical modifications to tubulin, color-coded 
as they are above, with known writer and eraser enzymes listed.  
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amino acids such as tyrosine and glutamate residues on the a-tubulin C-terminal tail (CTT) result 
in detyrosinated tubulin (dY), or del2- and del3-tubulin (Verhey and Gaertig 2007; Ian Yu, 
Garnham, and Roll-Mecak 2015; Gadadhar et al. 2017; Janke and Magiera 2020). Most PTMs 
label distinct microtubule populations in cells and as such are expected to encode for particular 
cellular functions. For example, acetylation marks are found on long-lasting microtubules in 
addition to decorating microtubule-based structures like the mitotic spindle and primary cilia. 
Additionally, neuronal microtubules typically have detyrosination and polyglutamylation marks 
which are thought to be important for neuronal differentiation (Mansfield and Gordon-Weeks 
1991; Eddé et al. 1990; Rüdiger et al. 1992; Audebert et al. 1994). 
 How PTMs are thought to alter microtubule function is due to interactions with other 
microtubule associated proteins (MAPs) and motor proteins. For example, tyrosinated tubulin is 
critical for initiation of dynein-dynactin transport, resulting in an increase in landing rates 
(McKenney et al. 2016). Polyglycylation and/or polyglutamylation of the b-tubulin CTT 
influences kinesin-1 binding. In addition, ɑ-tubulin acetylation drastically changes the binding and 
motility of kinesin-1 (Hammond et al. 2009; Reed et al. 2006), and polyglutamylation increases 
kinesin-3 pausing and run length (Lessard et al. 2019). Kinesin-2 motors have a 2.5x and 2x 
increase in velocity and processivity, respectively, on detyrosinated microtubules over tyrosinated 
microtubules (Sirajuddin, Rice, and Vale 2014). Some of these phenomena are especially 
highlighted in neurons where complex roads of modified microtubules stretch out into the complex 
network of dendrites and axons. In neuronal cultured neurons, kinesin-1 motors preferentially bind 
to and walk on acetylated microtubules, where kinesin-3 will tread on tyrosinated microtubules. 
With acetylation and tyrosination occurring on distinct populations of microtubules in neurons, 
chemical modifications seem to create separate tracks for particular kinesin motor families (Tas et 
al. 2017). These previous studies suggest microtubule PTMs form different tracks in cells that 
kinesin motors somehow recognize and “choose.” Other MAPs can also bind along the surface of 
the microtubule lattice and read PTMs. For example, plus-end binding proteins like EB1 and CLIP-
170 recognize tyrosinated form of tubulin through their CAP-Gly domain (Komarova et al. 2005; 
Roberts, Goodman, and Reck-Peterson 2014; Peris et al. 2006). Taken together, microtubule PTMs 
are important for many cellular functions and help direct protein-protein interactions throughout 
the cell.  
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1.2.2 Actin code 
 Like tubulin, actin also has a wide range of isotypes and chemical modifications. There are 
three a-isoforms of skeletal, cardiac, and smooth muscle actin, in addition to b- and g-isoforms 
found in non-muscle cells. These isoforms only differ by a few amino acids with most of the 
variation occurring towards the N-terminus of the protein (Hanson and Lowy 1963). Despite their 
sequence and structural similarities, actin isoforms have distinct roles in cells. For example, 
knockout of cardiac a-actin results in disorganization of cardiac myofibrils and mice without 
skeletal a-actin have weak muscles and die within a week whereas mice lacking smooth a-actin 
have defects in blood pressure regulation (Kumar et al. 1997; Crawford et al. 2002; Schildmeyer 
et al. 2000). However, in some cases isoforms have overlapping functions. Expressing cardiac a-
actin rescued muscle performance in skeletal a-actin knock-out models (Nowak et al. 2009). The 
cytoplasmic isoforms b- and g-actin are also nearly identical, with differences on the N-terminal 
residues. Knockout of b-actin, mice will die during early development, but otherwise knockout of 
g-actin or knock-down of b-actin has little impact on survival despite impacts on the formation of 
sensory hair cells and wound healing (Shawlot et al. 1998; Belyantseva et al. 2009). These studies 
indicate that particular action isotypes are critical for some functions but not necessarily for 
survival.  
 In addition to isotypes, actin can also be modified. Actin PTMs are found on 94 different 
side chains, meaning that about 45% of actin residues can be modified (Varland, Vandekerckhove, 
and Drazic 2019). That said, not all actin PTMs are present on the same molecule and instead are 
found in particular organisms, tissue types, or within particular regions of a cell. Most actin, both 
muscle and non-muscle isoforms, have acetylation on their N-terminus as part of their synthesis 
(Redman and Rubenstein 1984). Other common modifications are phosphorylation, oxidation, 
sumoylation, and methylation (Varland, Vandekerckhove, and Drazic 2019; Vedula and Kashina 
2018; Terman and Kashina 2013). Oxidation and reduction (redox) reactions on actin substrates 
impact actin dynamics, for example without actin oxidation cells will have abnormal actin 
polymerization and decreased neuron growth and development (Wilson and González-Billault 
2015). Impaired dynamics impacts cellular processes like cell division, where without oxidized 
actin filaments a cell cannot complete cytokinesis, and cell motility (Frémont et al. 2017; Fiaschi 
et al. 2006; Munnamalai and Suter 2009). Actin methylation occurs on multiple residues, but best 
characterized is methylation at position H73. Methylation of H73 regulates how flexible actin is 
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and is associated with actin polymerization and ATP hydrolysis (Nyman et al. 2002), and prevents 
primary dystocia (Wilkinson et al. 2018). While there are many other modifications to actin, 
suffice to say that the combination of isotypes and covalent modifications impact actin-based 
functions in cells and improper regulation of modifying enzymes leads to impairments in cellular 
and organismal functions.  
 
1.2.3 Histone code 
The most common or well-known system of PTMs is probably the histone code. Histones 
are the proteins around which DNA winds, and different modifications to histone isotypes lead to 
exposed or unexposed DNA. As such, histone modifications impact transcription, thus impacting 
protein expression of the whole cell.  
Much like the aforementioned proteins, histones have a number of isotypes. The 
combination of isotypes H2A, H2B, H3 and H4 come together to form an octamer. In addition, 
linker histone H1 has a different sequence and structure than the core histones (Kasinsky, Lewis, 
and Dacks 2001). The core histones, not including H1, are highly conserved across eukaryotes in 
both protein sequence and structure. Histone proteins have an essential role in gene regulation and 
protein expression, with some, like, H2A and H3 families, having specific roles for example in 
DNA repair, gene silencing, and gene expression (Talbert and Henikoff 2010a). Variations of some 
of these isotypes, CenH3, H3.3, H2A.Z, and H2A.X diverged in modern eukaryotes to perform 
specialized functions. CenH3, or centromere-specific histone variant H3, also known as CENP-A 
in humans, has 60% identity with canonical H3 yet replaces it during cell division because it 
interacts with microtubules (Santaguida and Musacchio 2009; Earnshaw and Rothfield 1985). 
Because chromosomes need to be divided evenly into daughter cells during mitosis, it’s important 
that DNA makes centromeric-mediated interactions with the microtubules that constitute the 
mitotic spindle. Similarly, variant H3.3 replaces H3 during S-phase when DNA is being replicated 
(Tagami et al. 2004). Even though only four amino acids differ between H3 and H3.3, deletions 
of H3.3 genes result in sterility and can be lethal (Hödl and Basler 2009; Cui, Liu, and Gorovsky 
2006). Like H3, H2 family has variations, H2A.Z, H2A.X, and macroH2A, where the former are 
found at transcription start sites to promote RNA Polymerase recruitment, and the latter are 
recruited for double-strand break repair in DNA (Zlatanova and Thakar 2008; Altaf et al. 2009; 
Buschbeck et al. 2009). Other less common histone variants exist and are discussed in (Talbert and 
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Henikoff 2010b). Even though most histones are highly conserved, most sequence differences are 
found in their flexible N-terminal tails which are accessible even when incorporated into 
nucleosomes. 
 
Histone proteins can be highly 
modified, with most of the chemical 
moieties found on the N-terminal tails of 
histones. Histone PTMs contribute to 
epigenetic regulation, because the 
modifications change and alter gene 
expression (Weinhold 2006). In addition to genetic sequence, epigenetic modifications alter gene 
activity without changing the DNA sequence and can be traced back to hereditary and 
Fig. 1.3 Histone Code. A) Cartoon 
showing how DNA (right) wraps 
around histones to form nucleosomes 
(center), which are further condensed 
into chromatin, and finally blue 
chromosomes (left). Chromatin can 
either be in a transcriptionally active or 
silent state depending on how loose or 
tightly it’s condensed. B) Cartoon 
showing the four histones incorporated 
into a nucleosome, H2A (purple), H2B 
(yellow), H3 (green), and H4 (red). 
Each histone has a long N-terminal tail 
which is highly modified with 
methylation (red), acetylation (yellow), 
and phosphorylation (orange) shown 
on amino acids depicted by their 
single-letter abbreviation. H2A and H3 




environmental factors. Histone tails are highly modified and the combination of PTMs dictate 
conformational changes in chromatin, thus leading to transcriptionally active or silent regions of 
the genome. Moreover, because of the slight sequence differences in histone isotypes and variants, 
histone PTMs are found on specific residues within the flexible N-terminal tails of particular 
isotypes, thus adding another layer of complexity to the system. For example, trimethylation of 
lysine 9 on H3 (H3K9me3) is associated with condensed chromatin (silent) while trimethylation 
of lysine 4 on histone 3 is enriched at promoter regions (active) (Fischle et al. 2005; Ekwall 2007; 
H. Santos-Rosa et al. 2002). The enzymes that modify histone tails are extremely specific to the 
residue, and sometimes require other modifications to be present. Indeed, some writer enzymes 
contain “reading” domains, for example many histone acetyltransferases (HATs) contain a 
bromodomain that recognizes acetylated lysine residues, meaning that the domain helps positively 
or negatively regulate activity (Jacobson et al. 2000). As such, a combinatorial code likely 
regulates whether a gene is transcriptionally active or silent, where multiple PTMs cooperatively 
restructure chromatin. For example, Ser10 phosphorylation on H3 inhibits Lys9 methylation but 
promotes Lys9 acetylation in such a way that marks for transcriptional activation (Rea et al. 2000; 
Cheung et al. 2000). This robustness or redundancy in function helps ensure the epigenetic code 
isn’t thrown off kilter without the presence of one particular modification, such that the loss of a 
single modification doesn’t disrupt proper transcriptional activities. Additionally, reversible 
reactions are critical because chromatin must fluctuate between condensed and exposed across the 
cell cycle. If the histone code does become dysregulated, gene expression and the cell cycle are 
directly affected. As such, mutations in histone readers, writers, and erasers often have diseases, 
especially cancers, associated with them (Helena Santos-Rosa and Caldas 2005; Cohen, Poręba, 
and Kamieniarz 2011).  
1.3 Research goals 
Typically, each of the aforementioned codes are researched and discussed in the confines 
of their own system: the tubulin code impacts microtubule dynamics and kinesin and dynein 
transport, the actin code changes cell motility and myosin processivity, and the histone code alters 
transcription. While these phrases are true, there is an increasing focus on how the codes 
communicate and impact one another in a cell and organism.  
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Most directly, cytoskeletal networks actin and microtubules are connected by protein cross-
linkers. Actin filaments can guide and stabilize microtubules near the cell periphery, and 
microtubules cannot grow neuronal growth cones if actin networks are disorganized (Waterman-
Storer and Salmon 1997; Zhou, Waterman-Storer, and Cohan 2002). Recently it was also found 
that actin filaments can be found inside the microtubule lumen using cryogenic electron 
tomography (Paul et al. 2020). Though the impact of actin inside the microtubule is not known 
yet, it’s hypothesized that it could alter microtubule dynamics or other protein interactions. Some 
microtubule associated proteins (MAPs) bridge actin and microtubules together. The spectraplakin 
family of proteins are spatiotemporally regulated and as such leverage the polarity of both actin 
filaments and microtubules (Zhang, Yue, and Wu 2017). MAP1 and MAP2 family proteins also 
cross-link polymers in axons particularly in developing neurons to allow for synaptic plasticity, 
and to help stabilize the actin ring during cleavage furrow of cell division (Tortosa et al. 2011; 
Morales and Fifkova 1989; Cueille et al. 2007). Additionally, tau protein, which binds to 
microtubules in neuron cells to establish neuronal polarity and stabilize microtubules, also 
organizes actin filaments. Disruption of actin within the growth cone perturbs tau localization, and 
conversely tau-deficient neurons show actin-dependent alterations in growth cone development 
(DiTella et al. 1994; Kempf et al. 1996).  
Histones can also make protein-protein interactions with cytoskeletal elements. Unlike 
tubulin, actin can exist in both the cytoplasm and the nucleus. Initial observational studies showed 
that actin filaments existed in the nucleus (Ishikawa, Bischoff, and Holtzer 1969) and has since 
been found to be important in regulating transcription, chromatin remodeling, and DNA repair 
(Fomproix and Percipalle 2004; Shen et al. 2000; Andrin et al. 2012). More specifically, increased 
actin filaments in the nucleus increases histone deacetylase activity, thus decreasing histone 
acetylation suggesting that actin can regulate histone modifying enzymes (Serebryannyy, Cruz, 
and de Lanerolle 2016). In addition, histones alter actin structure, with H1 able to help polymerize 
actin and H2A and H2B able to facilitate actin bundling (Magri, Zaccarini, and Grazi 1978; Sol et 
al. 2016). For microtubules that are not found in the nucleus, histones only have a chance to make 
protein-protein interactions during cell division when the nuclear envelope disappears. As 
previously discussed, histone variant CenH3 contacts kinetochore microtubules to ensure proper 
chromosome segregation.  
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Beyond direct or mediated protein-protein contacts, histones and the cytoskeleton share 
some PTM readers, writers, and erasers. Histone deacetylase 6 (HDAC6) acts on a-tubulin and is 
the only member of the histone deacetylase family that’s found in the cytoplasm (Boyault et al. 
2007). N-lysine methyltransferase 5A (KMT5A or SET8) methylates both lysine 4 of H4 in 
addition to tubulin at lysine 311 (Chin et al. 2020). SET8-dependent methylation has been 
associated with cell cycle progression and without SET8 cells have delayed mitotic progression 
and premature chromosome condensation (Wu and Rice 2011). These associated mitotic defects 
were thought to be histone dependent. However, because microtubules are critical in forming the 
mitotic spindle and can be methylated by the same enzyme performing histone methylation, there 
is a strong possibility that tubulin methylation is required for proper cell division. SMYD2, 
responsible for modifying histone 3 lysine 4 (H3K4me3) and p53 at lysine 370, can also methylate 
a-tubulin. SMYD2 methylation is mediated by cyclin-dependent kinases CDK4/6 which regulates 
methyltransferase activity, thus impacting both tubulin and histone PTMs (L. X. Li et al. 2020). 
Similarly, SETD2, a methyltransferase that canonically trimethylates histone 3 at position lysine 
36 has been implicated in tubulin methylation (Park et al. 2016). Imaging experiments show that 
methylation appears on minus-ends of microtubules in the mitotic spindle, and all but disappears 
when SETD2 is knocked-out. Moreover, mutations in SETD2 implicated in kidney cancers seem 
to tune histone and tubulin methylation. In addition, recent studies also show that SETD2 can also 
methylate actin and impact cell migration (Seervai et al. 2020).  
The following studies here aim to understand the biochemical underpinnings of how 
SETD2 distinguishes amongst its different substrates. By utilizing in vitro biochemical 
reconstitution with recombinant proteins, we want to understand how SETD2 recognizes and 
methylates tubulin in addition to actin. In addition, we want to determine if SETD2 has a 
preference for soluble dimers or monomers, or for microtubules and actin filaments respectively. 
To try and understand how SETD2 is regulated, we want to focus on the domains that contain 
mutations found in cancers, because in vivo data suggests that particular mutations seem to tune 
substrate activity. This system of cytoskeletal methylation by SETD2 needs to be studied in vitro 
so we can understand the necessary components and understand what is sufficient for methylation. 
These studies hope to identify particular domains or protein-protein interactions that regulate 
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Chapter 2 - Cytoskeletal Methylation by SETD2 
2.1 Forward  
This chapter will introduce cellular post-translational modifications, focusing on the Histone and 
Tubulin Codes. Working closely with our collaborators, the Walker Lab at the Baylor College of 
Medicine and Rathmell lab at Vanderbuilt, we explore tubulin methylation by SETD2 
biochemically. Part of this work is published in Kearns 2020 on bioRxiv and submitted (at time of 
thesis publication) to JBC. In addition, we find that SETD2 also methylates another cytoskeletal 
element, actin, published in Riyad 2020 Sci. Advances, in collaboration with the Walker lab of the 
Baylor College of Medicine.  
 
Figures 2.10B-C and 2.11B are reprinted from Science Advances 02 Oct 2020: Vol. 6, no. 40, 
eabb7854. DOI: 10.1126/sciadv.abb7854.  © The Authors, some rights reserved; exclusive 
licensee American Association for the Advancement of Science. Distributed under a Creative 




Microtubules are dynamic cytoskeletal polymers that maintain cell shape, serve as tracks 
for intracellular trafficking, provide a structural framework for cell division, and form the 
structural elements of cilia. How microtubules achieve their many varied cellular functions comes, 
in part, from a tubulin code of multiple isoforms of α- and β-tubulin dimers and varied post-
translational modifications (PTMs) (Verhey and Gaertig 2007; Gadadhar et al. 2017; Roll-Mecak 
2019). For example, differentiated cells express varying amounts of α- and β-tubulin isotypes to 
perform specialized roles (Leandro-García et al. 2010). Additionally, within each cell there are 
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subpopulations of microtubules with PTMs that further regulate microtubule-based functions. 
Analogous to how the histone code directs chromatin function, the combination of tubulin isotypes 
and PTMs comprise a tubulin code that specializes microtubule function in cells. 
One key chromatin modifier that contributes to both the histone and tubulin codes is SET 
domain containing 2 (SETD2). Our previous work demonstrated that SETD2 can methylate tubulin 
and that methylation occurs at Lysine 40 of α-tubulin (αTubK40me3) (Park et al. 2016). In a 
mitotic spindle context, which is where tubulin methylation has been found in cells, the correct 
bipolar geometry structure is critical for proper cell division. The microtubules comprising the 
mitotic spindle form interpolar microtubules to establish spindle bipolarity, aid in chromosome 
congression (Zhai, Kronebusch, and Borisy 1995; O’Toole, Morphew, and McIntosh 2019), and 
connect kinetochores with spindle poles to segregate chromatids (Maiato et al. 2017; Musacchio 
2015). As such, microtubules are highly dynamic and regulated during spindle formation and 
mitosis (T. Mitchison et al. 1986; T. J. Mitchison 1989; Lu and Johnston 2013; Petry 2016). 
Defects in the mitotic spindle, be they microtubule-, kinetochore-, or motor protein-driven, cause 
abnormal spindle structure resulting in chromosome mis-segregation and aneuploidy (Silkworth 
and Cimini 2012). Checkpoints during cell division exist to prevent improper cell division, but in 
disease or cancer states, aberrant cell growth and division override the elaborate checkpoint 
pathways (Vermeulen, Van Bockstaele, and Berneman 2003). In dividing cells, αTubK40me3 
localizes to the minus ends of microtubules that form the mitotic spindle, and is enzymatically 
added by SETD2. This methyltransferase also tri-methylates histones at the histone 3 lysine 36 
(H3K36me3) (Edmunds, Mahadevan, and Clayton 2008). Many aspects of SETD2 function are 
still unexplained, such as how SETD2 recognizes and differentiates substrates.  
Here, I took a biochemical reconstitution approach to define the minimal components 
required to methylate tubulin in vitro. Using a purified N-terminal truncated construct of SETD2 
which contains everything from the SET domain, beyond the SRI-domain, to the C-terminus of 
the enzyme (tSETD2) and recombinant human tubulin (Yu et al. 2016; Ti, Alushin, and Kapoor 
2018; Ti, Wieczorek, and Kapoor 2020), I had precise control of tubulin isotype and PTM-state in 
vitro and could generate mutant versions of tubulin to probe site selectivity of SETD2 methylation. 
I demonstrate that tSETD2 is sufficient to methylate tubulin in vitro and has a higher activity 
towards tubulin dimers over microtubules. I verify that the methylation site is on α-tubulin lysine 
40 (αTubK40), the same site that can be acetylated (L’Hernault and Rosenbaum 1985; LeDizet 
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and Piperno 1987; Davenport et al. 2014), and find that tSETD2 sequesters tubulin in solution, 
thus altering microtubule dynamics. I found that SETD2 recognizes the negatively-charged C-
terminal tail of α-tubulin. Additionally, work with collaborators found that SETD2 also methylates 
actin as well, and I found that globular and filamentous actin are both substrates because the 
methylation site, K68, is accessible in both populations. This work begins to understand how 
cytoskeletal substrates are recognized for SETD2-mediated methylation.  
2.3 Results 
2.3.1 SETD2 can methylate tubulin in vitro 
To investigate the underlying biochemistry of tubulin methylation by SETD2, we generated a 
truncated construct containing everything from the catalytic SET domain to the C-terminus in 
addition to a FLAG-tag for cellular imaging and affinity purification (tSETD2-FLAG, Fig. 2.1B). 
This construct was previously shown to rescue histone and tubulin methylation in vivo (Hacker et 





Fig. 2.1 Purification of tSETD2-Flag. A-B) Cartoon diagram depicting domains of A) Full 
length SETD2 and B) tSETD2-FLAG, the latter being the construct we utilize in experiments, 
henceforth. While there are many domain architectures in this protein (depicted in various grey 
colors), we will be focusing on the catalytic SET domain (red), and SRI domain (purple). Note 
that the C-terminal FLAG tag (yellow) will be used for purification, immunofluorescence, and 
western blots in later experiments. C-D) 280 nm absorbance spectra of C) Ion exchange and D) 
size exclusion chromatography. E) Coomassie gel and F) anti-FLAG western blot of fractions 
of whole cell lysate (WCL), soluble fraction after ultracentrifugation (Sol), FLAG-bead elution 
(FLAG), post-ion exchange (Ion), and size exclusion chromatography fractions (SEC).  
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We first tested to see how this construct expressed in cells. We transfected tSETD2-FLAG 
into COS-7 cells and cultured them before fixing and immunostaining them with antibodies anti-
FLAG and -tubulin, and DNA (DAPI) followed by fluorescent secondary antibodies for imaging. 
Using fluorescence microscopy, we observed cells mostly in interphase (Fig. 2.2A) and were lucky 
enough to catch a handful of cells undergoing mitosis. During interphase, tSETD2-Flag 
predominantly localized in the nucleus whereas during mitosis tSETD2-FLAG dispersed 
throughout the cell’s cytoplasm (Fig. 2.2B). This is comparable to full length SETD2-FLAG 
localization in cells (Fig. 2.2A-B). These data suggest that tSETD2-FLAG construct localizes 
normally in vivo and, as such, likely folds properly and behaves as expected in cells. 
I purified this truncated construct with a series of purification steps (Fig. 2.1C-F). First, 
HEK293 cells overexpressing tSETD2-FLAG were harvested (Whole cell lysate, WCL) and 
Fig. 2.2 SETD2 overexpression in COS-7 cells. Top) Interphase cells and Bottom) Mitotic 
cells stained for DNA (DAPI, dark blue), tubulin (cyan), and FLAG (pink).  
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clarified (Sol.) before being added to FLAG resin. FLAG elution was run through an ion exchange 
column (Fig. 2.1C) before size exclusion chromatography (Fig. 2.2D). Fractions were analyzed by 
Coomassie gel (Fig. 2.1E) and western blot with anti-FLAG antibodies (Fig. 2.1F).  
I then turned towards biochemical experiments to monitor methyltransferase activity. To 
do this. I utilized an assay that monitors the production of S-adenosyl-homocysteine (SAH), a 
byproduct of SAM-dependent methyl transfer, via enzyme-coupling resulting in fluorescence 
(Dorgan et al. 2006). In this coupled assay, SAH is converted into resorufin. With a standard curve 
of resorufin concentrations and fluorescence, fluorescence over time is converted to 
methyltransferase activity. When tSETD2-FLAG is given its methyl donor SAM in addition to 
either histone H3 peptide (aa 21-44) or porcine brain tubulin substrate, the observed fluorescence 
over time suggests methyl transfer activity towards both substrates (Fig. 2.3A). To control for any 
potential auto-methylation of tSETD2-FLAG, enzyme without substrate with SAM was monitored 
as well and the background signal was subtracted (Fig. 2.3C). When the concentration of substrate 
is varied, the measured initial velocities generate a Michaelis-Menten plot of reaction velocity as 
a function of substrate concentration (Fig. 2.3B). From this type of kinetic plot, kinetic constants 
can be derived like the Michaelis-Menten constant, KM, a kinetic constant describing the 
concentration of substrate that results in half the enzyme’s maximal activity, and the vmax, the 
maximal activity rate (Fig. 2.3D). KM values for tubulin and H3 peptide substrates (0.75±0.06 mM 
and 0.45±0.32 mM, respectively) suggest that tSETD2-FLAG has slightly different affinities 
depending on substrate. However, the vmax with tubulin protein (3.98±0.12 nmol/min) as a 
substrate was lower compared to H3 peptide (5.41±0.48 nmol/min), suggesting that tSETD2 has a 
higher activity toward the H3 peptide. Taken together, these data indicated that, while the 





At physiological temperatures, tubulin will self-assemble into microtubule polymers and 
grow and shrink in a process called dynamic instability (Walker et al. 1988; Desai and Mitchison 
1997; Manka and Moores 2018). As such, we next wanted to determine if tSETD2-FLAG was 
Fig. 2.3 Methylation activity of tSETD2-FLAG. A-B. tSETD2-FLAG with various 
concentrations of histone H3 peptide (blue) or tubulin (black) substrates. A) Fluorescence traces 
and B) Michaelis-Menten curves. C. tSETD2-FLAG without substrate to background subtract 
automethylation. D. Kinetic values calculated from B.  
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modifying tubulin dimers or microtubule polymers (Fig. 2.4A). To test this, we used small 
molecules: taxol to stabilize polymerized microtubules and podophyllotoxin to inhibit 
polymerization thus ensuring a tubulin dimer state (Jordan, Thrower, and Wilson 1992; Ojima et 
al. 1999), which we confirmed visually with cryoEM (Fig. 2.4B), We performed a similar 
methyltransferase assay as before, monitoring fluorescence over time (Fig. 2.4C). From this, we 
found that the activity of tSETD2-FLAG is almost three-fold higher for dimers than microtubule 
polymers when the substrate concentration is 5 μM (Fig. 2.4D). That said, when we varied the 
substrate concentration to calculate Michaelis-Menten constant and vmax, we found that the 
binding kinetics are similar. For tubulin dimers and microtubules, KM values are 0.057±0.038 μM 
and 0.048±0.013 μM, respectively (Fig. 2.4E). This suggested that tSETD2-FLAG has a slightly 
higher affinity for microtubules but higher activity towards tubulin dimers.  
To verify that tSETD2-FLAG can bind microtubules, a microtubule sedimentation assay 
was performed. This assay assesses protein-microtubule interactions by measuring the amount of 
protein that co-pellets with microtubules by centrifugation followed by SDS-PAGE analysis of the 
supernatant and pellet fractions. If tSETD2-FLAG can bind to microtubules, signal at 125 kDa 
would be in the pellet fraction, whereas if it does not associate to the polymer, it would be in the 
soluble fraction. A strong signal appeared in the soluble fraction at 125 kDa, the size of tSETD2-
FLAG, nevertheless, there was a small signal in the pellet fraction as well (Fig. 2.4F) suggesting 
that tSETD2-FLAG can bind to microtubules However, without a negative control of tSETD2-
FLAG alone, the protein found in the pellet fraction could just be aggregation, but we believe this 
to be unlikely. Taken together, tSETD2-FLAG can bind and methylate both tubulin dimers and 







To determine the 
tubulin methylation 
site by tSETD2-
FLAG, we used 
recombinant single-
isotype tubulin 
rather than porcine 
brain tubulin. The 
tubulin that we have 
been using so far, 
again, is sourced 
from pig brains and 
as such it has many 
different isotypes 
and PTMs. In trying 
to study a particular 
component of the 
complex tubulin 
code, we did not 
want all of these 
Fig. 2.4 tSETD2-FLAG has higher activity with tubulin dimers. A) Cartoon schematic of 
microtubules and tubulin dimers. B) CryoEM micrographs of left) taxol stabilized microtubules 
and right) tubulin dimers. C) Fluorescence traces of methyltransferase activity of tSETD2-
FLAG with microtubules (black) and tubulin dimers (grey). D) Quantification of 
methyltransferase activity of tSETD2-FLAG. E) Michaelis-Menten kinetic plots varying 
substrate concentration of microtubules (black) or tubulin dimers (grey). F) Co-pelleting assay 
showing tSETD2-FLAG binding to microtubules (pellet).  
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compounding factors of existing modifications. In addition, having many isotypes and other 
modifications will make identification of a single, and sparse, modification difficult to detect 
biochemically. As such, I reduced the complexity of the system by using a recombinant tubulin. 
Historically, it has been difficult to express and purify recombinant tubulin because of the complex 
folding pathway tubulin requires (Lewis, Tian, and Cowan 1997; Beghin, Galmarini, and 
Dumontet 2007; Matthews 2009). As such, tubulin cannot be expressed and purified in bacteria, 
and instead higher-order organisms and expression systems are required, like yeast, insect, or 
mammalian cells (Johnson et al. 2011; Minoura et al. 2013; Yu et al. 2016).  
For our studies, we expressed and purified single isotype αTub1B/βTub3 using an insect 
expression plasmid generously gifted from the Kapoor Lab. We used this isotype combination 
because it is the one most expressed in the brain and as such would serve as a good comparison to 
our experiments so far (Leandro-García et al. 2010; Bitterman et al. 2018). In this dual expression 
system, each tubulin monomer has an affinity tag separated by a TEV cleavage site in order to 
utilize affinity chromatography during purification yet still be able to have tag-less tubulin at the 
end of the day (Fig. 2.5A). After using affinity columns in tandem, HisTrap (Fig. 2.5B) and 
StrepTrap (Fig. 2.5C), size exclusion is performed post-TEV cleavage to get purified tubulin 
dimers (Fig. 2.5D). Each fraction was analyzed by SDS-PAGE gel (Fig. 2.5E) In order to use this 
purified tubulin for experiments, it was necessary to concentrate the protein down to at least 3 
mg/mL before flash freezing and storing at -80C.  
Once we had purified tubulin, we verified that it would form functional microtubule 
polymers. We did this by using a non-hydrolyzable GTP analogue, GMPCPP, to make stabilized 
microtubules. To image microtubules via total internal reflection fluorescence microscopy 
(TIRFM), we additionally spiked the polymerization mixture with biotinylated and fluorescently 
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tagged porcine brain tubulin. We next 
determined if these microtubules are 
functional as molecular roads for 
kinesin motility. We overexpressed 
kinesin-1 (Rattus norvegicus (Rn) 
KIF5C 1-560) with an m-Citrine tag 
(KIF5C560-mCit) in COS-7 cells and 
generated a cell lysate containing these 
fluorescently labeled proteins. Adding 
Fig. 2.5 Purifying functional single-
isotype tubulin from insect cells. A) 
Cartoon schematic of left) alpha and 
beta tubulin and right) single isotype 
construct of αTub1B/βTub3. B-E) 
Purification of single isotype tubulin 
using B) HisTrap affinity, C) 
StrepTrap affinity, and D) size 
exclusion chromatography. E) 
Coomassie gel electrophoresis of 
each step along the purification. F) 
Single isotype tubulin was 
polymerized in the presence of 
biotin- and 674-labeled porcine brain 
tubulin for TIRF microscopy. 
Fluorescently labeled kinesin-1 
motor (KIF5B-560-3xmCit) lysate 
was added and motility was observed 
over time. Kymograph analysis on 
microtubules shows single-molecule 




these kinesins from cell lysate to a flow chamber in the presence of ATP, we were able to monitor 
single-molecule motility showing that our microtubules are functional (Fig. 2.5F).  
Previous studies indicated that methylation occurred on αTubK40, a site that is found on a 
flexible loop of α-tubulin (Fig. 2.6A). We wanted to verify these previous findings and seek to 
identify any other methylation sites to tubulin by SETD2. As such we performed site-directed 
mutagenesis to generate αTubK40A (Fig. 2.6B-C), I verified that the αTubK40A-containing 
tubulin can form microtubules imaged via TIRFM (Fig. 2.6D). I then carried out methyltransferase 
activity assays with both the WT and αK40A single-isotype recombinant tubulin. I found that 
tSETD2-FLAG had reduced activity against αTubK40A when compared to the WT control (Fig. 
2.6E-F).  
The decrease in methyltransferase activity with αK40A suggested that either there are 
additional methylation sites on tubulin, or that the K40 loop of α-tubulin is important for substrate 
recognition by tSETD2-FLAG. To identify other methylation sites, mass spectrometry experiment 
was performed mixing tSETD2-FLAG in the presence and absence of SAM in the presence and 
absence of recombinant tubulin substrate, either WT or aTubK40A. Reaction mixtures were 
digested with chymotrypsin, followed by LC-MS/MS, and analyzed with PEAKS X. Interestingly, 
we were only able to detect methylation in the reaction with SAM with WT recombinant tubulin, 
suggesting that there are no other detectable methylation sites on tubulin (Fig. 2.6 G). The residual 
activity we see in the methyltransferase activity, as such, could be background methylation of 
tSETD2 of another protein that was pulled down during purification. Additionally, our mass 
spectrometry shows only a single methylation on αK40, whereas previous studies using tubulin 
from cells identified trimethylation. These discrepancies suggest that there may be other 
methyltransferases in cells that perform mono- or di-methylation to prime tubulin for methylation 
by SETD2, or that any additional methylation site not being picked up by our protein digestion 
and mass spectrometry parameters. That said, our data shows that tSETD2-FLAG methylates 




Fig. 2.6 tSETD2-FLAG methylates αK40A. A) Cartoon schematic showing the K40 loop in 
yellow. B-C) αTub1B/βTub3 αK40A was expressed and purified from insect cells and analyzed 
by B) size exclusion chromatography and C) Coomassie gel. D) Purified αK40A was co-
polymerized with biotin- and 488-labeled porcine tubulin for TIRF and formed microtubules. 
E) Representative fluorescence traces of tSETD2-FLAG against WT and αK40A single isotype 
tubulins. F) Calculated methyltransferase activity of tSETD2-FLAG with WT or αK40A 
tubulin. Each dot indicates the average result from a single experiment across n=4 experiments. 
G) Mass spectrometry analysis of tubulin peptides. Table shows the only peptide modified in 
the presence of both tSETD2-FLAG and SAM, followed by the number of peptides either 




2.3.3 Tubulin methylation alters microtubule dynamics 
Some components of the tubulin code are known to alter microtubule dynamics. For example, 
αTub1B/βTub3, has a much higher catastrophe rate and slower growth rate compared to 
αTub1B/βTub2B, due to slightly different lateral contacts made by the different isotypes within 
the microtubule lattice (Ti et al. 2018). In vivo, aTubK40 acetylated microtubules are more 
resistant to cold and nocodazole or colchicine treatment, however the in vitro data remains 
inconsistent. In a similar vein, tyrosinated or detyrosinated microtubules seem to have little impact 
on tubulin polymerization in vitro. That said, tyrosination can impact microtubule dynamics by 
regulating the interactions between severing proteins like kinesin-13 and MCAK (Ems-McClung 
et al. 2010, McHugh et al. 2019). Similarly, microtubule glutamylation can regulate microtubule 
fragmentation by spastin (Valenstein et al. 2016). Some modifications have a polymerization 
inhibition effect, like the acetylation of βTubK252 or phosphorylation of βS172 (Janke et al. 2020). 
Given the possibility that tubulin modifications can impact microtubule dynamics, we sought to 
determine if tubulin methylation altered polymerization and depolymerization rates. 
To determine if methylation altered dynamics, recombinant single isotype tubulin 
polymerization dynamics were observed by TIRF microscopy. First, we generated single isotype 
GMPCPP seeds spiked with streptavidin- and rhodamine-labeled porcine tubulin. From there, we 
added single isotype tubulin in the presence of tSETD2-FLAG with and without methyl donor 
SAM, along with 5% 488-labeled porcine tubulin for imaging. As a control, we performed 
microtubule dynamics assays with just recombinant tubulin. Microtubule dynamics were imaged 
using total internal reflection microscopy (TIRF-M) for 30 minutes.  
Generated kymographs from time-lapse images were analyzed to measure the growth and 
shrinkage rates of both the minus- and plus- ends, along with the rate of catastrophe and maximum 
microtubule length. In the presence of tSETD2-FLAG both with and without SAM, we noticed 
that plus-ends grew and shrunk slower with methylated tubulin than with un-modified tubulin. 
Minus-end growth was also slower with methylated tubulin, but minus-end shrinkage was slightly 
quicker. Also, we saw a lower catastrophe frequency when microtubules were formed in the 
presence of tSETD2-FLAG despite forming shorter microtubules overall. Taken together, it’s 
tempting to say that methylated tubulin largely suppresses microtubule dynamics at both the 
minus- and plus- ends. However, because these results are seen with and without the methyl donor 
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SAM, more likely the presence of tSETD2-FLAG protein is indirectly influencing microtubule. 
dynamics, perhaps by altering the amount of free tubulin to be incorporated into microtubules, 




2.3.4 SETD2 recognizes α-tubulin C-terminal tail 
Previous work has demonstrated that the interaction between SETD2 and RNA Pol II 
involves electrostatic interactions between positively-charged residues in the SETD2 SRI domain 
and negatively-charged phosphorylated C-terminal repeat domains of RNA Pol II. This led us to 
hypothesize that SETD2 recognition of tubulin involves similar charge-charge interactions, 
particularly between positively-charged residues in the SETD2 SRI domain and the negatively-
charged C-terminal tails (CTTs) of α- and/or β-tubulin. Even though there is no sequence 
Fig 2.7 Presence of SETD2 alters microtubule dynamics. A) Cartoon schematic of dynamic 
assay with pink GMPCPP seeds and green dynamic microtubules. B) Kymographs of 
microtubules dynamics (left) without tSETD2-FLAG or (right) with tSETD2-FLAG and SAM. 
C-H) Microtubule dynamic properties measured of the C-D) plus-ends, E-F) minus ends with 
C&E) growth rates and D&F) shrinkage rates displayed. G) Catastrophe frequency of the plus-
ends. H) Length of microtubule growth during the experiment.  
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conservation between C-terminal of RNA Pol II or tubulin tails, both phosphorylated RNA Pol II 
and tubulin tails have a similar pattern of negative charge.  
Truncations of the CTTs of either α-tubulin (αTub1BΔCTT/βTub3 = ΔαTubCTT) or β-
tubulin (αTub1B/βTub3ΔCTT = ΔβTubCTT) were generated (Fig. 2.8A-C). Both of these 
generated constructs were transformed into baculovirus. Tailless tubulin dimers were expressed 
and purified from insect cells using a combination of affinity and size-exclusion chromatography 
(Fig. 2.8B-C). Thus far, when IP experiments were performed, an antibody with an epitope that 
recognizes the β-tubulin CTT was used. This antibody clearly would not work for recognizing 
ΔβTubCTT, and as such an antibody that recognizes the N-terminus of α-tubulin, TU-01, was used 
for western blot analysis (Fig. 2.8D).  
tSETD2-FLAG binding to tailless tubulins was assessed by using a co-
immunoprecipitation assay. Immobilized tSETD2-FLAG was incubated with either ΔαTubCTT or 
ΔβTubCTT tubulin proteins and then we analyzed the bead-bound fraction. Whereas tSETD2-Flag 
pulled down porcine brain and ΔβTubCTT tubulins, it was less able to co-precipitate ΔαTubCTT 
tubulin (Fig. 2.8E-F). This shows that the CTT of a-tuublin is required for tSETD2-FLAG binding. 
From these experiments, we conclude that tSETD2-Flag binds to tubulin via the negatively 
charged CTT of α-tubulin.  
Next, I checked to see if the CTT influenced the ability of tSETD2-FLAG to microtubules. 
The ability of the ΔαTubCTT or ΔβTubCTT tubulin proteins to form microtubules was assessed 
by using the purified tubulin to first generated GMPCPP seeds spiked with biotin- and 
fluorescently- labeled porcine tubulin, and then polymerizing off the seeds to form microtubules, 
as seen by TIRF microscopy (Fig. 2.9A). Next, a copelleting assay was performed to assess if 
tSETD2-FLAG could bind to ΔαTubCTT or ΔβTubCTT microtubules, where binding to the lattice 
would mean a 125 kDa signal in the pellet (P) fraction (Fig. 2.9B). tSETD2-FLAG can bind to 
WT, detyrosinated, and ΔβCTT microtubules but less well to ΔαCTT microtubules. This suggests 





 Fig. 2.8 tSETD2-FLAG recognizes α-tubulin C-terminal tail. A) Cartoon of tailless tubulin, 
either ΔαCTT (top) or ΔβCTT (bottom). These tubulin mutations were introduced into the single-
isotype αTub1B/βTub3 tubulin and expressed and B-C) purified from insect cells. Purified 
tubulin was analyzed by B) size exclusion chromatography and C) Coomassie gel electrophoresis, 
in addition to D) western blot with two different tubulin antibodies, TU-01 which recognizes the 
N-terminus of a-tubulin or E7 which recognizes the C-terminus of b-tubulin. E) 
Coimmunoprecipitation of tSETD2-FLAG with porcine brain, ΔαCTT, or ΔβCTT tubulins. 
Shown are western blots of the bead pellets with antibodies to tSETD2-FLAG (FLAG, top) and 
the N-terminus of α-tubulin (TU-01, bottom). The far-left column shows the input for the reaction 
with porcine tubulin. F) Quantification of amount of tubulin copelleting with tSETD2-FLAG 
compared to input. Each dot represents the percent bound from one experiment and the line 






2.3.5 SETD2 methylates actin 
Similar to microtubules, actin filaments are a critical component of the cell’s cytoskeletal network. 
Actin fibers contribute to muscle contraction, cell motility, cell division and signaling, cytokinesis 
and cell morphology, and cargo transport with myosin motors (Cooper 2000; Blanchoin et al. 
2014). Based on ours and others’ findings that SETD2 modifies microtubules, we were curious to 
identify any other cytoplasmic or cytoskeletal substrates. Performing a co-IP with SETD2 and 
whole cell lysate, we found that it could bind endogenous actin in addition to actin purified from 
Fig. 2.9 tSETD2-FLAG cannot bind ΔαCTT microtubules. A) TIRF micrographs of 
GMPCPP-stabilized single-isotype αTub1B/βTub3 microtubules WT (black), dY (grey), 
ΔαCTT (green), and ΔβCTT (blue) spiked with biotin- and 488-labeled porcine tubulin. B) Co-
pelleting of tSETD2-FLAG with single isotype microtubules, analyzing soluble (S) and pellet 
(P) fractions. C) Quantification of amount of tSETD2-FLAG in the pellet fraction. Each dot 
represents the percent in the pellet from one experiment. 
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rabbit muscle (Seervai et al. 2020). Surprisingly, we were able to detect SETD2 both in nuclear 
and cytoplasmic compartments of interphase cells, suggesting that SETD2 does not entirely return 
to the nucleus after cell division. Fluorescence microscopy staining against actin, SETD2, and a 
pan-trimethyl mark also shows co-localization of these components in the cytoplasm, especially 
along the periphery of cells (Seervai et al. 2020). In SETD2 knockout cells, the tri-methyl mark 
does not appear on actin filaments, suggesting a SETD2-dependence to actin methylation (Seervai 
et al. 2020). Together, this suggests that SETD2 is able to methylate actin filaments in cells.  
Because there are different 
isoforms of actin in cells, we wanted to 
identify the type of actin SETD2 could 
methylate by using actin purified from 
cardiac muscle, smooth muscle, and 
skeletal muscle in addition to human actin 
purified from mammalian (HEK293) and 
bacterial (E. coli) cells (Fig. 2.10A-B). 
tSETD2-FLAG was able to methylate 
Fig. 2.10 tSETD2-FLAG methylates 
actin. A) Cartoon schematic of 
different actin sources used in the B-C) 
Methyltransferase activity assay. B) 
Representative fluorescent traces of 
tSETD2-FLAG with actin substrate 
natively purified from cardiac, smooth, 
or skeletal muscle, or recombinantly 
overexpressed from HEK293 or E. coli 
TP7 cells. C) Calculated 
methyltransferase activity of tSETD2-
FLAG against actin substrates. The bars 




actin from all of these sources, except actin purified from bacterial cells, indicating that proper 
folding of actin or modifications may be required for methylation by SETD2. This is seen both in 
the fluorescent traces in addition to the calculated activity at 5 μM actin substrate concentration 
(Fig. 2.10B-C).  
Next, we were curious to find out if tSETD2-FLAG methylated monomer or polymer actin, 
because Fig. 2.10B-C did not take polymerization state into account. To ensure a monomeric state, 
we treated actin purified from rabbit skeletal muscle with Latrunculin A, an actin polymerization 
inhibitor (Coué et al. 1987; Ayscough et al. 1997; Spector et al. 1983; Fujiwara et al. 2018). The 
actin state with and without LatA was verified using negative stain electron microscopy (Fig. 
2.11A). From the collected micrographs, we see that actin filaments can be observed in the absence 
of LatA but that actin cannot form filaments in the presence of LatA. 
Next, we performed the fluorescence-based methyltransferase assay 
using these two populations of actin, either monomer or polymer, and 
calculated the activity by measuring the initial velocity of the reactions. 
tSETD2-FLAG activity was similar in the presence or absence of LatA 







micrographs of actin 




(LatA) at different 
concentrations. B) 
Representative 









same (Fig. 2.11B). This suggests that the site of methylation is in an accessible site when actin is 
in filament form. 
Next, we wanted to identify the site of actin methylation by tSETD2-FLAG. We 
hypothesized that the site could either be K18 or K68 (Fig. 2.12A-B) based on sequence similarity 
with histone and tubulin. To test these two sites, we generated peptides either containing amino 
acids 14-36 or 63-84, with the target lysine mono-, di-, or tri-methylated, or lacking - methyl 
groups. Additionally, we used the tSETD2-Flag catalytically dead R1625C mutant as a negative 
control. As expected, the R1625C mutant has low or no activity for any substrate. In contrast, 
tSETD2-FLAG was able to methylate both peptides with ~2-fold higher activity for the peptide 
containing K68 (Fig. 2.12B). Furthermore, tSETD2-FLAG had the higher activity toward the di-
methylated peptide, yet still could methylate non- and mono-methylated peptides.  
To test whether ActK68 is methylated in cells, mass spectrometry was performed on lysates 
from wild-type and SETD2-deficient cells by the Walker lab. Amongst the actin peptides 
identified, Act68me was found in SETD2-proficient but not in SETD2-deficient cells (Seervai et 
al. 2020). Moreover, performing mass spectrometry on purified tSETD2-FLAG, ActK68me was 
detected in trace amounts, suggesting that tiny amounts of actin are co-purifying with tSETD2-
FLAG but more importantly that SETD2 can methylate ActK68 in vivo when overexpressed (Fig. 
2.12C). Given that K68 is in a relatively accessible site along actin filaments (Fig. 2.12A), this 
explains our previous findings that tSETD2-FLAG has comparable activity with monomer and 






actin at K68. A) 
Ribbon diagram of 
left) actin filament and 
right) globular actin 
with two potential sites 
of methylation colored 
blue (K18) or green 
(K68). B) Peptides of 
two potential sites of 
methylation were 
synthesized with no, 
mono, di, or tri 
methylation at the 
prospective lysine, 
either K18 (left, blue) 
or K68 (right, green). 
These peptides were 
mixed with tSETD2-
FLAG, either WT or 
R1625C, and SAM and 
activity was measured 
and calculated. Bars 
show average +/- SD of 
n=3 experiments. C) 
Actin peptides 
containing K68 identified in mass spectrometry analysis of tSETD2-FLAG purified from HEK293 
cells, suggesting trace amounts of actin are co-purifying and being modified by tSETD2-FLAG in 
vivo shown as the average number of peptides across three experiments. 
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2.4 Discussion 
2.4.1 Accessing the methylation site of tubulin 
Since the first study identified tubulin methylation in cells by SETD2 (Park et al. 2016), 
our work provides some biochemical underpinnings of tubulin methylation. Beyond SETD2, 
recent studies have found other tublin methyltransferases. The histone H4 lysine 20 methylating 
enzyme SET8, along with transcription factor LSF, has been identified as a modifier of α-tubulin 
at K311 (Chin et al. 2020), which would be on the surface of tubulin if incorporated into the 
microtubule lattice.  Although the cellular implication of loss of K311 methylation in cells remains 
to be determined, these data suggest that transcription factors, LSF in the case of SET8, can recruit 
writer enzymes to target tubulin and other dual chromo-cytoskeletal modifiers could link histone 
and tubulin codes. Other proteins, similarly, have been linked to both codes like tubulin tyrosine 
ligase like 12 (TTLL12). TTLL12 has both SET-like and TTL-like domains, despite being unable 
to catalyze either histone methylation or tubulin detyrosination (Brants et al. 2012). However, 
altered TTLL12 expression results in changes to histone 4 lysine 20 trimethylation (H4K20me3) 
suggesting that it could act as a reader for histone and tubulin modifications. Our work here, in 
addition to a growing body of literature, identifies and characterizes tubulin methylating and dual 
chromo-cytoskeletal regulating enzymes. 
By exploiting known tubulin-targeting agents, we found that SETD2 preferentially 
methylates the dimeric form of tubulin vs. microtubule polymers, though is able to methylate both 
tubulin states. Our mass spectrometry experiments only identified a single site, αTubK40, that is 
methylated. Because the K40 residue resides on a flexible loop of α-tubulin that is located within 
the lumen of a polymerized microtubule (Soppina et al. 2012; Eshun-Wilson et al. 2019), it could 
be accessible to modifying enzymes when tubulin is in either the soluble dimer or microtubule 
form. However, given the large size of the  full length endogenous SETD2 protein (~290 kDa) and 
the restricted size of the microtubule lumen (~17 nm diameter), it has been puzzling how SETD2 
could access the K40 residue within the microtubule lumen.  
One possibility for how SETD2 can access K40 is the lumen is that it enters from the end 
as αTAT does. Acetylation on microtubules is randomly distributed and activity is diffusion-
limited (Akella et al. 2010; Szyk et al. 2014). A second possibility is that SETD2 enters along the 
lattice. Microtubules sometimes have defects in their lattice, due to high mechanical stress (Dye, 
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Flicker, and Lien 1992; Schaedel et al. 2015) or microtubule severing enzymes (Vemu et al. 2018; 
Triclin et al. 2018). Total microtubule catastrophe and depolymerization, despite lattice defects 
and removed tubulin dimers, can be rescued with the addition of GTP or GTP-like analog tubulin 
(Dimitrov et al. 2008; de Forges et al. 2016; Aumeier et al. 2016). Moreover, the nucleotide state 
of tubulin impacts the microtubule lattice structure with either the GTP or hydrolyzed GDP form 
corresponding to an elongated straight or compact and bent form of tubulin when incorporated into 
the lattice (Weisenberg, Deery, and Dickinson 1976; Buey, Díaz, and Andreu 2006; Alushin et al. 
2014; Piedra et al. 2016; Ayukawa et al. 2020). Together, the dynamics present in the microtubule 





Methyltransferase activity was monitored using a fluorescence-based time dependent assay that 
coupled the consumption of the methyl donor, S-adenosyl-methionine (SAM) to a colorimetric 
readout. These types of experiments helped us determine the differential activity of tSETD2-FLAG 
amongst histones, tubulin, and actin (Fig. 2.3 & Fig. 2.10), between tubulin dimers and 
microtubules (Fig. 2.4), and with wild-type and K40A recombinant tubulin (Fig. 2.6). However, 
we had some interesting observations looking at the fluorescence traces themselves during our 
analysis.  
We noticed that in the methyltransferase reaction with histone peptide, increasing 
concentrations of substrate resulted in comparable fluorescence end-point values, despite having 
differing initial slopes of fluorescence over time (Fig. 2.3A, left). We would expect that different 
concentrations would have different end-point values increasing with substrate concentration. 
Despite this, our Michaelis-Menton analysis of the concentration-dependent activity (Fig. 2.3B, 
left) showed comparable kinetic rates of tSETD2-FLAG with H3 peptide as previous studies with 
histone peptides and nucleosome substrates (Eram et al. 2015) (Fig. 2.3D). Additionally, for 
tubulin substrates, we noticed that there were two slopes across time, suggesting kinetic 
complexity. We would anticipate that the two slopes are due to the mixed substrate population of 
tubulin dimers and microtubules, but more careful kinetic analysis would be required to know for 
certain. Given this, the Michaelis-Menton analysis (Fig 2.3B, right) and the subsequent kinetic 
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constants derived (Fig. 2.3D) has limitations in their interpretation given the mixed substrate 
population. When we look at methyltransferase reactions with known populations of tubulin 
dimers and microtubules, see two distinct slopes depending on the population (Fig. 2.4C). 
However, we also noticed that there is a small burst-like shape early on in the microtubule 
fluorescence trace. This burst is not seen in reactions with the recombinant tubulin (Fig. 2.6E). As 
such, we would expect that there could be a small amount of tubulin dimers in the microtubule 
population that are consumed more quickly by tSETD2-FLAG. Again, however, more careful 
experimental set-up and kinetic analysis would be required to determine the underlying 
mechanism.  
While these interesting kinetics are tempting to derive implications from, without different 
types of experiments we cannot interpret the existing data. To better understand what’s going on, 
future experiments will have to tease apart the competition between tubulin dimers and 
microtubules. Moreover, other types of analyses, beyond Michaelis-Menton and steady state 
kinetics, could be done to tease apart the complexity of the reaction. For example, transient state 
enzyme kinetic reactions could help characterize steps along the pathway of an enzyme-catalyzed 
reaction such as substrate binding, catalytic reactions, and product release.  
 
2.4.3 Multiple modifications at αK40 
Our mass spectrometry analysis identified α-tubulin K40 as the only detectable site of methylation 
by tSETD2 on the recombinant single-isotype αTub1B/βTub3. This confirms and extends the 
previous work where tri-methylation was detected at this site in mammalian cells (Park et al. 
2016).  In our mass spectrometry experiments, we were only able to detect a mono-methylation 
mark on αK40 whereas in cells, trimethylated tubulin was detected (Park et al. 2016). The 
canonical SETD2 activity is with di-methylated histone substrates. While this suggests that mono- 
or di-methylated tubulin could be a preferred substrate for SETD2, it is known that SETD2 can 
mono-methylate substrates (Chen et al. 2017), but typically will di- or tri-methylate substrates. As 
such, tubulin methylation may require priming by other methyltransferases before SETD2 makes 
its mark in cells.  
Although mutation of K40A did not completely abolish methyltransferase activity 
measured in the fluorescence-based assay, we were unable to detect any other methylated peptides 
for α- or β-tubulin by mass spectrometry. It is possible that SETD2 is able to methylate another 
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tubulin residue that we have been unable to detect in our mass spectrometry analysis, perhaps 
because the methylated peptide does not ionize well or the amount is below the limit of detection. 
It is also possible that tSETD2-FLAG or a co-purifying methyltransferase enzyme from HEK293 
cells is able to methylate a contaminating protein that co-purifies with tubulin from the insect cells 
and/or with tSETD2-FLAG from the HEK293 cells. Further work will be required to discern 
between these possibilities.  
The K40 residue of α-tubulin is also known to be acetylated by alpha tubulin 
acetyltransferase (αTAT) (Akella et al. 2010; Shida et al. 2010). Whether SETD2 and αTAT 
compete for access to the K40 residue has been unclear. Given our results demonstrating a higher 
activity of SETD2 towards soluble tubulin and recent work demonstrating that αTAT1 
preferentially acetylates polymerized microtubules and enters the microtubule lumen (Shida et al. 
2010; Kormendi et al. 2012; Szyk et al. 2014; Coombes et al. 2016; Ly et al. 2016), the two 
enzymes appear to work on tubulin in different contexts. Specifically, SETD2 preferentially 
methylates soluble tubulin whereas αTAT preferentially acetylates polymerized tubulin. The 
interplay between these enzymes is likely to play a role in specific cellular events. For example, 
elevated levels of α-tubulin acetylation correlate positively with metastatic potential (Boggs et al. 
2015) and αTAT inhibits cancer cell motility (Lee et al. 2018), whereas SETD2-mediated tubulin 
methylation corresponds with genomic stability and correct mitotic spindle formation (Park et al. 
2016; Chiang et al. 2018). 
Interestingly, both SETD2 (Eram et al. 2015; Kearns et al., 2020) and αTAT (Shida et al. 
2010) display slow enzymatic rates toward the tubulin substrate in vitro. SETD2 also shows similar 
low kcat values towards purified nucleosome substrates (Eram et al. 2015). In a histone methylating 
context, SETD2 is typically recruited by other protein complexes (e.g. IWS1, SPT6, and RNA Pol 
II) (Yoh et al. 2007; Cermakova et al. 2019) suggesting that substrate binding and enzyme kinetics 




 Performing microtubule dynamics assay with single isotype tubulin in the presence of 
tSETD2-FLAG with and without the methyl donor SAM, we found that dynamic properties 
changed when the enzyme was present, but not necessarily due to enzymatic activity. Because 
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dynamics were the same with and without SAM, the added tSETD2-Flag is likely acting in an 
indirect manner, perhaps by sequestering free tubulin dimers. As such, the alteration in the tubulin 
economy, and not methylated tubulin, would impact microtubule dynamics. Our mass 
spectrometry results indicate that tubulin methylation does not efficiently label many tubulin 
dimers: less than 20% of single-isotype αTub1B. We’d suspect that microtubules with 
modifications that sparse will likely not have drastic differences in dynamics compared to un-
modified. My dynamic assay indicates that tSETD2-FLAG may alter the amount of free tubulin 
dimers. In cells, microtubules are assembled from a finite pool of tubulin dimers (a so-called 
“tubulin economy”). Tubulins are a valuable resource that can be used to create polymers, organize 
the cytoskeleton, and regulate other microtubule-associated proteins like motors (Ohi, Strothman, 
and Zanic 2021). With soluble tubulin highly enriched at the centrosome (Baumgart et al. 2019), 
it is possible that SETD2 sequestration of free tubulin wouldn’t be impacting tubulin 
polymerization and instead is creating a pool of methylated tubulin for the spindle to utilize at the 
centrosome to create the mitotic spindle.  
 Other post-translational modifications have been studied in terms of stabilizing or 
destabilizing, rather than altering the tubulin economy. For example, acetylation of aTubK40 is 
known to mark cold- and stress-stabilize microtubules and as such the acetylated microtubules 
have lower catastrophe and depolymerization rates (Piperno, LeDizet, and Chang 1987; Xu et al. 
2017). Conversely, however, overexpression of HDAC6, a microtubule deacetylase, in cells has 
no impact on microtubule growth or dynamics (Zilberman et al. 2009) and tubulin acetylation 
reduces the microtubule nucleation rate while increasing the depolymerization rate (Portran et al. 
2017). Together, these findings suggest that acetylation at αTubK40, while increasing the 
stabilization and resistance of microtubules, can also inhibit polymerization or increase rates of 
depolymerization depending on microtubule state. Acetylation at βTubK252 and phosphorylation 
of βS172 both inhibit tubulin polymerization (Chu et al. 2011; Ori-McKenney et al. 2016). Levels 
of tyrosination/detyrosination seem to have no effect on tubulin polymerization, but some 
depolymerizing enzymes like kinesin-13 (MCAK, or KIF2C) preferentially act on tyrosinated 
microtubules (Raybin and Flavin 1977; Ferreira et al. 2020). This last finding of tubulin 
modifications read by other enzymes, thus having a larger impact on dynamics gets at the interplay 
of the tubulin code with the microtubule associated protein (MAP) code. MAPs that bind to and 
sometimes decorate the microtubule lattice can have a larger impact on microtubule dynamics in 
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addition to motor protein motility (Monroy et al. 2020). As such, the tubulin code could be 
underlying the MAP code, both indirectly having an impact on cytoskeletal dynamics in cells. 
 Tubulin methylation in particular is only detected at the minus ends of mitotic spindle 
microtubules. Compared to the enzymatic rates of tubulin methylation (slow), cell division occurs 
very quickly and, more specifically, microtubules that connect to the kinetochore are very dynamic 
(T. Mitchison et al. 1986; T. J. Mitchison 1989). As such, I would anticipate that other proteins, 
structural or enzymatic, would have to be present near the centrosomes in order to promote 
microtubule nucleation and dynamics. Future work will distinguish the mechanism of how 
methylated tubulin is incorporated into microtubules in cells and identify other protein-protein 
interactions key to the proper formation of the mitotic spindle. 
 
2.4.5 A tail of tubulin recognition 
Our results also demonstrate that tSETD2 requires the CTT of α-tubulin, a negatively-charged 
region of the protein, for binding. This is interesting given previous work demonstrating that the 
SRI domain of SETD2 interacts with the phosphorylated, and thus negatively-charged, C-terminal 
repeat domains of Pol II (Rebehmed et al. 2014; Kizer et al. 2005; Kanu et al. 2015). It is thus 
tempting to speculate that charge-charge interactions are key for recognition of substrates by the 
SRI domain of SETD2. However, actin has recently been shown to be methylated by SETD2 
(Seervai et al. 2020) and unlike tubulin and RNA Pol II, actin does not have a long flexible 
negatively-charged tail or loop within its structure. However, in these studies, actin methylation 
by SETD2 required other binding partners, namely the Huntingtin protein, HTT, and the actin 
binding adaptor protein HIP1R. Future work will be required to delineate the mechanism by which 
SETD2 recognizes actin and other substrates. 
While our results suggest that SETD2 does not compete with α TAT for modification of 
the K40 residue, it likely competes with other tubulin-interacting proteins and/or modifying 
enzymes that target the CTT. The flexible CTTs of tubulin subunits extend from the surface of the 
microtubule and form a negatively-charged surface that appears to serve as a recognition site for a 
large number of microtubule associated proteins.  For example, tubulin tyrosine ligase (TTL) 
makes critical electrostatic interactions with α-tubulin residues E445, E446, and E447 in order to 
align the CTT within the active site (Prota et al. 2013). The VASH-SVBP complex that removes 
the terminal tyrosine from α-tubulin (Liu et al. 2019; F. Li et al. 2020) makes electrostatic 
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interactions with a compound that mimics the tubulin CTT residues (F. Li et al. 2019). Similarly, 
the tubulin CTTs are essential for microtubule recognition by tubulin tyrosine ligase-like 7 
(TTLL), an enzyme that adds glutamate chains to the CTTs of both α- and β-tubulin (Garnham et 
al. 2015; Szyk et al. 2011). As such, our work adds SETD2 to the growing list of tubulin modifying 
enzymes that recognizes tubulin CTTs. Given that the SRI domain of SETD2 makes electrostatic 
interactions with the negatively charged CTT of α-tubulin, additional negative charge from 
polyglutamates added by TTLL enzymes could change the binding and activity of SETD2 to 
tubulin. Future work will need to look at the crosstalk between tubulin PTMs. 
 
2.4.6 SETD2 activity is actin’ up 
In addition to methylating tubulin, SETD2 can modify actin as well. In coordination with binding 
partners HTT and HIP1R, actin is methylated by SETD2 thus regulating actin polymerization 
dynamics and cell migration (Seervai et al. 2020). Moreover, actin is methylated at K68 near the 
DNaseI binding loop (D-loop, amino acids 39 to 43). This loop contains several modifiable 
residues (Varland, Vandekerckhove, and Drazic 2019), and is structurally proximal to another 
methylated lysine residue K84 (M.-M. Li et al. 2013). In addition to methylation, K68 itself is 
susceptible to acetylation, SUMOylation, and ubiquitination (Terman and Kashina 2013), 
suggesting a regulation of modifications at this position.  
While SETD2 methylates both polymerized and monomeric actin in vitro (Fig. 2.11B), the 
K68me3 mark is more abundant on actin filaments in cells (Seervai et al. 2020). In cells, LatA 
treatment leads to a loss of methylated actin, yet had little effect on actin polymerization. This 
could mean the lack of actin methylation leads to less dynamic actin that is resistant to LatA-
induced polymerisation. Because SETD2-deficient cells have a loss of dynamic actin, the 
susceptibility to depolymerization/repolymerization cycles of methylated actin could also 
contribute to actin dynamics in SETD2-proficient cells during migration (Svitkina 2018). 
Moreover, cells from Setd2-null mice had disorganized stress fibers and lamellipodia (Hu et al. 
2010), suggesting that the disruption of the actin cytoskeleton, in addition to loss of histone 
H3K26me3 and tubulin spindle methylation, is detrimental.  
Actin is a target for modifications on 94 of its amino acids, comprising over 90% of total 
modifiable residues (Varland, Vandekerckhove, and Drazic 2019; Terman and Kashina 2013), yet 
the structural and functional implications of many PTMs remain unknown. One actin modification 
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that has been structurally characterized, however, is methylation at histidine 73 (H73) by SETD3 
(Wilkinson et al. 2018). H73 methylation has been known for over fifty years, but was only 
recently identified to be modified by SETD3, a histone methyltransferase that also methylates 
histone 3 at lysine 4 and 36 (Eom et al. 2011). Structural analysis of SETD3 with actin peptides 
suggest that both proteins must undergo significant conformational changes upon binding to each 
other, with loops in SETD3 shifting more than 4Å (Guo et al. 2019; Wilkinson et al. 2018; Zheng, 
Zhang, and Li 2020). However, the actin and histone peptides bind in opposite N-to-C orientations 
and the actin H73 and histone H3K36 are recognized by distinct residues of the SET domain 
(Zheng, Zhang, and Li 2020). With SETD3 and SETD2 sharing a homologous catalytic SET 
domain, this has implications in how histone methyltransferases bind and recognize their 
substrates. Beyond just actin methylation, our findings with SETD2 expand the paradigm that 
some epigenetic machinery has chromato-cytoskeletal activity important for modifying both 
nuclear and cytoskeletal proteins. As such, we find that SETD2 methylates key components: 
histones during transcription, microtubules during cell division, and actin for cell migration, 
though future work will need to identify how SETD2 is localized to different parts of the cell to 
perform its myriad methylation functions.  
 
2.5 Materials and Methods 
Plasmids. 
An active truncated SETD2 construct (1418-2564) with a FLAG affinity tag (tSETD2-Flag) for 
mammalian pInducer expression was gifted by the Walker Lab. Single isoform αTub1B/βTub3 
plasmid encoding Homo sapiens α-tubulin 1B and β-tubulin 3 in pFastBac Dual vector 
(ThermoFisher 10712024) was obtained from the Kapoor lab for insect cell expression (Ti, 
Wieczorek, and Kapoor 2020). Point mutations and domain deletions were generated using 
QuickChange site-directed mutagenesis with Q5 Polymerase (NEB). All plasmids were verified 
by DNA sequencing. A truncated, constitutively active kinesin-1 [rat KIF5C(1-560)] (Cai et al., 




SETD2. tSETD2-Flag was transfected into HEK 293 Freestyle cells with FectoPRO transfection 
reagent (116-010) and cells were harvested 48 hours later at 5K rpm for 15 mins (Beckman JLA 
8.1 (363563)). Pellet was suspended in lysis buffer (50 mM HEPES pH 7.5, 50 mM MgCl2, 150 
mM NaCl, cOmplete protease inhibitor tablet (Sigma Aldrich, 4693159001) and cells were lysed 
with 20 strokes of a dounce homogenizer. This was ultracentrifuged (Beckman Ti70 337922) at 
40K rpm for 40 mins and the supernatant was filtered with 1.0 um glass fiber filter (Pall 
Laboratory) and incubated with FLAG M2 affinity beads (Sigma Aldrich) equilibrated in lysis 
buffer for 3 hours. Beads were rinsed with 3 column volumes (CV) of wash buffer (50 mM NaPi 
pH 7.2, 150 mM NaCl, 5 mM BME), 3 CV salt buffer (wash buffer at 500 mM NaCl), and again 
with wash buffer before elution buffer (wash buffer with 300 ng 3x-FLAG peptide (Sigma 
Aldrich)) was added and incubated with beads overnight. Eluent was then run over ion exchange 
column (DEAE Sepharose, GE Life Sciences) on a 0-75% salt buffer gradient, and size exclusion 
chromatography (Superose 6 Increase 10/300, Fisher Scientific) with gel filtration buffer (50 mM 
NaPi pH 7.2, 150 mM NaCl, 5 mM BME, 5% glycerol). Fractions were pooled and concentrated 
down with an Amicon Ultra 100K MWCO centrifugal filter unit and snap frozen in liquid nitrogen 
and stored at -80C.  
 
αTub1B/βTub3 tubulin. As previously described in (Ti et al. 2018; Ti et al. 2020). Briefly, the Bac-
to-Bac system (Life Technologies) was used to generate recombinant baculovirus in sf9 cells. High 
Five cells (Thermo Fisher, B85502), grown to 3 million cells/ml in Lonza Insect XPRESS (Fisher 
Scientific, BW12-730Q), were infected with P3 viral stocks at ~10 mL/L. Cells were cultured in 
suspension at 27°C and harvested at 60 hours after infection. The following steps were done on 
ice or at 4°C. Cells were lysed in an equal volume of lysis buffer (50 mM HEPES, 20 mM 
imidazole, 100 mM KCl, 1 mM MgCl2, 0.5 mM β-mercaptoethanol, 0.1 mM GTP, 3 U/ml 
benzonase, 1X Roche Complete EDTA-free protease inhibitor, pH 7.2) by dounce homogenization 
(20 strokes) and the homogenate was centrifuged at 55,000 rpm in a Type 70 Ti rotor (Beckman 
Coulter) for 1 hr. The supernatant was then filtered through a 0.22 μm membrane (Fisher Scientific, 
09740113) and loaded onto a 5 ml HisTrap HP column (GE life science 17-5247-01) pre-
equilibrated with lysis buffer. The column was washed with 35 ml lysis buffer until the UV 
absorption reached baseline, then eluted with nickel elution buffer (1X BRB80 (80 mM PIPES, 
1mM MgCl2, 1mM EGTA), 500 mM imidazole, 0.2 mM GTP, 2 mM β-mercaptoethanol, pH 7.2). 
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The fractions containing proteins were pooled, diluted 3-fold with lysis buffer and loaded one 5 
ml StrepTrap HP column (GE life science 29-0486-53). The column was washed with 25 ml 66% 
lysis buffer + 33% nickel elution buffer, 25 ml of wash buffer 1 (1X BRB80, 1 mM β-
mercaptoethanol, 0.1 mM GTP, 0.1 % Tween-20, 10% glycerol, pH 7.2), and 25 ml of wash buffer 
2 (1X BRB80 1 mM β-mercaptoethanol, 0.1 mM GTP, 10 mM MgCl2, 5 mM ATP, pH 7.2). The 
bound protein was then eluted with ∼5 ml StrepTrap elution buffer (1XBRB80, 20 mM Imidazole, 
2 mM β-mercaptoethanol, 0.2 mM GTP, 3 mM desthiobiotin, pH 7.2). The StrepTrap eluate was 
mixed with 4 mg of previously purified TEV protease (∼8 mg/ml stored in 40 mM HEPES, 150 
mM KCl, 30%(w/v) glycerol, 1 mM MgCl2, 3 mM β-mercaptoethanol, pH 7.5) and incubated for 
2 hr on ice. The TEV-digested protein solution was concentrated with an Amicon Ultra 50K 
MWCO centrifugal filter unit (Millipore UFC901024) to 2 mL, and loaded onto a Superdex 200 
Increase 10/300 GL column equilibrated in size-exclusion buffer (1XBRB80, 5%(w/v) glycerol, 
0.2 mM GTP, 2 mM β-mercaptoethanol, pH 6.8). Tubulin eluted at ∼15 ml and was concentrated 
to >3 mg/ml with an Amicon Ultra 50K MWCO centrifugal filter unit. The purified tubulin was 
snap frozen in liquid nitrogen and stored at -80°C. Tail-less tubulin eluted at ~18 mL and 
concentrated with an Amicon Ultra 30K MWCO centrifugal filter unit, but otherwise was purified 
the same way.  
 
Methyltransferase assay.  
Activity of tSETD2-Flag constructs was surveyed using a Methyltransferase Fluorescence Assay 
Kit (Cayman Chemical, 700150). This continuous enzyme-coupled assay continuously monitors 
SAM-dependent methyltransferases by generating a fluorescent compound, resorufin, from the 
reaction product, AdoHcy. Fluorescence is analyzed with an excitation wavelength of 530-540 nm 
and an emission wavelength of 585-595 nm using a PHERAstar Plate Reader (BMG Labs). A 
standard curve of resorufin concentration and fluorescence was used to determine concentration-
dependent fluorescence. The initial velocities of the reaction curves were obtained by linear-
regression, and then were plotted in a concentration-dependent manner to obtain Michaelis-
Menten plots, and as such values for Km and vmax (Prism Version 8.1.1). 
Dimer or microtubule stabilization. Microtubule polymerization was inhibited by the addition of 
50 μM of podophyllotoxin (Millipore Sigma, P4405). Microtubule stabilization occurred with 100 
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μM taxol (Cytoskeleton Inc, TXD01). Stocks were made at 2 mg/mL and then diluted to perform 
methyltransferase assay in BRB80.  
 
Mass Spectrometry. 
Purified single isoform tubulin and tSETD2-Flag were incubated at molar ratio of 5:1 with excess 
S-adenosylmethionine (Sigma Aldrich, 86867-01-8) for 2 hours at room temperature. Enzyme 
mixture was digested with fresh Chymotrypsin (Sigma Aldrich, 11418467001) and put onto 
a  Thermo Scientific mass spectrometer with an Orbitrap Fusion Tribrid with ETD and a Q 
Exactive HF equipped with a nano-LC system (Dionex RSLC-nano). Analysis of PTMs conducted 
with PEAKS X. 
 
Pull-down assay.  
FLAG M2 beads were blocked with 3% BSA in PBS for 1 hour and equilibrated in the reaction 
buffer (tSETD2-Flag size-exclusion buffer, described previously). tSETD2-Flag protein (WT or 
variants) was added at 20 μM with a putative binding partner for 2 hours in the presence of SAM. 
For tubulin, 0.25 mg/mL of porcine tubulin (Cytoskeleton, Inc.) was used, for actin, 0.25 mg/mL 
of rabbit actin (Cytoskeleton, Inc. AKL99) was used, and for RNA Polymerase II, 10 μL of 
HEK293 Freestyle clarified lysate was used. Beads were spun down and the supernatant was 
collected as the fraction of unbound substrate. The beads were then resuspended in the reaction 
buffer to the total reaction volume, and the same amount of supernatant and beads were added to 
SDS-PAGE gel. Analysis of binding was conducted by western blot with the following antibodies: 
anti-FLAG (Sigma Aldrich, A9469, 1:1000), anti-tubulin antibodies E7 (DSHB, AB_528499, 
1:1000) and/or TU-01 (Abcam, ab7750, 1:1000), anti-RNA Polymerase II (Abcam, ab193468, 
1:1000), and anti-actin (Fisher Scientific, MS1295P0), with secondary antibody anti-mouse (Enzo 
Life Science, ADI-SAB-100-J, 1:1000) or anti-rabbit (Enzo Life Science, ADI-SAB-300-J, 
1:1000), respectively. Binding was quantified by measuring the background-subtracted intensity 
of each band with Fiji ImageJ (Schindelin et al. 2012) as a fraction of the input intensity. Each 




COS7 (CRL-1651) cells transiently expressing tSETD2-Flag constructs (Lipofectamine 2000 and 
OptiMEM) were fixed with 4% formaldehyde in PBS, treated with 50 mM NH4Cl in PBS to 
quench unreacted formaldehyde and permeabilized with 0.2% Triton X-100 in PBS. Subsequently, 
cells were blocked in blocking solution (0.2% fish skin gelatin in PBS). Primary antibodies tubulin 
(DSHB, AB_528499, 1:2000) and Flag (Abcam, ab205606, 1:2000), and secondary antibodies 
were applied in blocking solution at room temperature for 1 h each, washing in between with 
blocking solution. Nuclei were stained with 10.9 μM 4′,6-diamidino-2-phenylindole (DAPI) and 
cover glasses were mounted in ProlongGold (Life Technologies). Cells were incubated 3x for 5 
min in blocking solution to remove unbound antibodies. Images were collected on an inverted 
epifluorescence microscope (Nikon TE2000E) equipped with a 60x, 1.40 numerical aperture oil-
immersion objective and a 1.5x tube lens on a Photometrics CoolSnapHQ camera driven by NIS-
Elements (Nikon) software. 
 
Microtubule polymerization.  
GMPCPP-stabilized. We first prepared αTub1B/βTub3 microtubule seeds. Tubulin was thawed, 
mixed with GMPCPP (final 1.5 mM), diluted to ∼ 1.5 mg/ml with 1XBRB80+5% glycerol, 
centrifuged at 90,000 rpm for 10 min at 4°C (TLA120.1 Beckman Coulter), and then polymerized 
by incubation at 37°C for 30 mins. The microtubules were pelleted at 90,000 rpm for 10 min at 
37°C (TLA120.1 Beckman Coulter) and re-suspended in warm (37°C) 1XBRB80 supplemented 
with 1 mM TCEP. Next, we used these microtubule seeds to polymerize GTP-bound 
αTub1B/βTub3. Another aliquot of recombinant tubulin was thawed, diluted to a final 
concentration ∼3 mg/ml (1XBRB80, 33% glycerol, 1 mM GTP), and spun at 90,000 rpm for 10 
min at 4°C (TLA120.1 Beckman Coulter). After incubation at 37°C for 2 mins, the supernatant 
was mixed with GMPCPP-seeds from the prior step and then incubated at 37°C for 30 mins 
followed by centrifugation at 90,000 rpm for 10 min at 37°C (TLA120.1 Beckman Coulter). The 
microtubule pellets were rinsed twice with 100 μl warm (37°C) EM buffer (1X BRB80, 1 mM 
DTT, 0.1 mM ATP, 0.05% Nonidet P-40) before suspending in 30 μl cold EM buffer and then 
incubated on ice for 1 hr. After a centrifugation at 90,000 rpm for 10 min at 4°C, the supernatant 
containing depolymerized GDP-tubulin (∼2 mg/ml, measured by Bradford assay) was mixed with 
GMPCPP (final 2 mM) and then incubated on ice for 10 mins. After an incubation at 37°C for 2 
mins, the protein solution was mixed with 30 μl warm (37°C) EM buffer followed by 37°C 
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incubation for another 1 hr. The polymerized GMPCPP-microtubules were pelleted by 90,000 rpm 
for 10 min at 37°C (TLA120.1 Beckman Coulter) and suspended in warm (37°C) EM buffer. 
Taxol-stabilized. αTub1B/βTub3 tubulin were thawed, mixed with GTP (final concentration 2 
mM), diluted to ∼ 1 mg/ml with 1XBRB80 with 5% glycerol, and centrifuged at 90,000 rpm for 
10 min at 4°C (TLA120.1 Beckman Coulter) to remove any aggregates from the freeze-thaw cycle. 
After incubation at 37°C for 2 mins, the supernatant was mixed with 1 μM taxol (final 0.1 μM, 
37°C 10 mins), followed by mixing with 10 μM taxol (final 1 μM, 37°C 10 mins), and then mixed 
with 100 μM taxol (final 10 μM, 37°C 15 mins). The microtubules were pelleted at 90,000 rpm 
for 10 min at 37°C (TLA120.1 Beckman Coulter) and re-suspended in warm (37°C) EM buffer 
containing 15 μM taxol. 
 
Single Molecule TIRF Assay  
Flow cell and experimental set up. Single isoform microtubules were polymerized with taxol 
stabilization as described above, but spiked with 2% labeled porcine brain tubulin (HiLyte). 
Microtubules were stored in the dark at room temperature for up to 2 weeks. Flow cells were 
prepared by attaching a #1.5 mm2 coverslip (Thermo Fisher Scientific) to a glass slide (Thermo 
Fisher Scientific) using double-sided tape. Microtubules were diluted in a freshly made BRB80 
buffer supplemented with 10 μM taxol, infused into flow cells, and incubated for four minutes to 
allow for nonspecific absorption to the glass. Flow cells were then incubated with blocking buffer 
[30 mg/mL casein in P12 buffer (12 mM Pipes/KOH pH 6.8, 1 mM MgCl2, 1 mM EGTA) 
supplemented with 10 μM taxol] for four minutes. Flow cells were then infused with motility 
mixture (0.5–1.0 μL of COS7 cell lysate [see below for preparation], 25 μL P12 buffer, 15 μL 
blocking buffer, 1 mM ATP, 0.5 μL 100 mM DTT, 0.5 μL, 0.5 μL 20 mg/mL glucose oxidase, 0.5 
μL 8 mg/mL catalase, and 0.5 μL 1 M glucose), sealed with molten paraffin wax. 
Imaging conditions. Microtubules were imaged on an inverted Nikon Ti-E/B total internal 
reflection fluorescence (TIRF) microscope with a perfect focus system, a 100 × 1.49 NA oil 
immersion TIRF objective, three 20 mW diode lasers (488 nm, 561 nm, and 640 nm) and EMCCD 
camera (iXon+ DU879; Andor). Image acquisition was controlled using Nikon Elements software 
and all assays were performed at room temperature. Motility data were analyzed by first generating 
maximum intensity projections to identify microtubule tracks (width = 3 pixels) and then 
generating kymographs in ImageJ (National Institutes of Health). Only motility events that lasted 
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for at least three frames were analyzed. Furthermore, events that ended as a result of a motor 
reaching the end of a microtubule were included; therefore, the reported run lengths for highly 
processive motors are likely to be an underestimation. 
Kinesin cell lysate preparation. COS-7 (African green monkey kidney fibroblasts, American Type 
Culture Collection, RRID:CVCL_0224) were grown at 37°C with 5% (vol/vol) CO2 in Dulbecco’s 
Modified Eagle Medium (Gibco) supplemented with 10% (vol/vol) Fetal Clone III (HyClone) and 
2 mM GlutaMAX (L-alanyl-L-glutamine dipeptide in 0.85% NaCl, Gibco). Cells are checked 
annually for mycoplasma contamination and were authenticated through mass spectrometry (the 
protein sequences exactly match those in the African green monkey genome). 24 hr after seeding, 
the cells were transfected with plasmids encoding for the expression of KIF5B (1-560) motor 
tagged with three tandem monomeric citrines (3x-mCit) transfection reagent (Mirus), and Opti-
MEM Reduced Serum Medium (Gibco). Cells were trypsinized and harvested 24 hr after 
transfection by low-speed centrifugation at 3000 x g at 4°C for 3 min. The pellet was resuspended 
in cold 1X PBS, centrifuged at 3000 x g at 4°C for 3 min, and the pellet was resuspended in 50 μL 
of cold lysis buffer [25 mM HEPES/KOH, 115 mM potassium acetate, 5 mM sodium acetate, 5 
mM MgCl2, 0.5 mM EGTA, and 1% (vol/vol) Triton X-100, pH 7.4] with 1 mM ATP, 1 mM 
phenylmethylsulfonyl fluoride, and 1% (vol/vol) protease inhibitor cocktail (P8340, Sigma-
Aldrich). Lysates were clarified by centrifugation at 20,000 x g at 4°C for 10 min and lysates were 
snap frozen in 5 μL aliquots in liquid nitrogen and stored at −80°C. 
 
Actin polymerization and inhibition. Actin for the methyltransferase assay came from the 
following sources: rabbit skeletal muscle actin (Cytoskeleton, Inc., AKL95), bovine cardiac 
muscle actin (Cytoskeleton, Inc., AD99), chicken gizzard smooth muscle actin (Cytoskeleton, Inc., 
AS99), β-actin human recombinant protein (OriGene, TP303643), and β-actin human recombinant 
protein (OriGene, TP720518)]. Actin purified from rabbit skeletal muscle was natively 
purified  and gifted by the Higgs lab was polymerized at X in 10 mM Tris-HCl (pH 7.5), 2 mM 
MgCl2, 50 mM KCl, and 1 mM ATP. Latrunculin A was also gifted from the Higgs lab and 
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Chapter 3: Mutations in SETD2 Tune Substrate Binding 
3.1 Forward 
This chapter will introduce cancer mutations that impact histone and tubulin methylation, focusing 
on clear cell renal cell carcinoma mutations found in SETD2. This work identifies the mechanism 
of tubulin methylation by SETD2 and is published in Kearns 2020 bioRiv and submitted to JBC.  
3.2 Introduction 
 
Cancer is, in part, due to mutations in genes that result in aberrant cell division. Many cancers 
including kidney, lung, bladder, glioma, and leukemia have inactivating mutations in histone 
methylating proteins, like SETD2 (Fontebasso et al. 2013; Zhu et al. 2014; Mar et al. 2017; Kim 
et al. 2019). SETD2 is an S-adenosyl-methionine (SAM)-dependent lysine methyltransferase, 
which on chromatin is responsible for histone-3 lysine 36 trimethylation (H3K36me3), a mark 
associated with gene transcription (Edmunds, Mahadevan, and Clayton 2008; J. Li, Duns, Westers, 
Sijmons, Van Den Berg, et al. 2016). Loss of SETD2 is embryonic lethal in part because its ability 
to trimethylate H3K36 is non-redundant (Hu et al. 2010). In clear cell renal cell carcinoma 
(ccRCC), SETD2 is the second most frequent mutation and is estimated to contribute to 10-15% 
of all ccRCC cases (Dalgliesh et al. 2010; Hakimi et al. 2013; Ho et al. 2014; W. Liu et al. 2015; 
J. Li, Duns, Westers, Sijmons, Van Den Berg, et al. 2016). For example, an arginine-to-cysteine 
mutation at position 1625 (R1625C), found within the catalytic SET domain, ablates 
methyltransferase activity and is thought to be pathogenic as it is associated with poor prognosis 
in the clinic. Another mutation, arginine-to-histidine at position 2510 (R2510H), occurs in the 
Set2-Rpb1-interacting (SRI)-domain at the C-terminus of SETD2 but does not result in loss of 
H3K36me3 (L. Liu et al., 2017.; Hacker et al. 2016; Park et al. 2016), suggesting that pathogenicity 
associated with this SRI domain mutation is not due to loss of histone methylation.  
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Our previous work demonstrated that SETD2 can methylate tubulin and that methylation 
occurs at Lysine 40 of α-tubulin (αTubK40me3) (Park et al. 2016; Kearns et al., 2020). In dividing 
cells, αTubK40me3 localizes to the minus ends of microtubules that form the mitotic spindle (Park 
et al. 2016).  Loss of SETD2 in ccRCC and knock-out of SETD2 in cells results in genomic 
instability and mitotic defects such as multipolar spindles, lagging chromosomes during anaphase, 
chromosomal bridging during cytokinesis, and micronuclei (Park et al. 2016; Chiang et al. 2018). 
These phenotypes correlated with a drastic reduction in both H3K36me3 and αTubK40me3 
methylation. Reintroduction of a truncated form of wild-type SETD2 (tSETD2) containing the 
SET and SRI domains rescued both histone and tubulin methylation as well as the mitotic defects 
(Park et al. 2016; Hacker et al. 2016). In contrast, expression of tSETD2 with the R2510H mutation 
in the SRI domain rescued histone methylation but was unable to rescue tubulin methylation or 
the mitotic defects  (Park et al. 2016; Hacker et al. 2016) (Fig. 3.1A), suggesting that a loss of 
SETD2 activity can result in  increased mitotic defects in a tubulin-dependent manner.  
Here, I sought to understand how SETD2 methylation is regulated and how mutations in 
the enzyme alter activity by reconstituting tubulin methylation with ccRCC-associated SETD2 
mutations. Utilizing binding and activity assays, I verified that tSETD2-R2510H cannot methylate 
tubulin, and identified that the lack of activity is due to ablated substrate binding. I generated 
additional SRI-domain mutations and tested if any of these residues were also important for tubulin 
binding. Interestingly, positively charged residues within the SRI domain are more important for 
tubulin binding where aromatic residues are more critical for RNA Pol II binding. Surprisingly, 
none of these residues impact actin binding, suggesting an alternative mechanism for actin 
substrate recognition. Together, these start to provide a mechanistic basis for the regulation of 
SETD2 amongst its various substrates. 
3.3 Results 
3.3.1 ccRCC-associated SRI domain mutant cannot methylate or bind tubulin 
We started investigating the two most common ccRCC mutations in SETD2 by generating the 
associated point mutations in our tSETD2-FLAG construct (described in Ch. 2) to make either the 
SET-domain mutation, R1625C, or the SRI-domain mutation, R2510H (Fig. 3.1A). These 
constructs were then expressed and purified from mammalian cells, as with the WT enzyme 
described in Chapter 2 (Fig. 3.1B-C). tSETD2-FLAG constructs, either the R1615C or R2510H, 
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were expressed in COS-7 cells and immunostained to identify cellular localization (Fig. 3.2). Both 
mutants typically localize in the nucleus during interphase (Fig. 3.2C) and are cytoplasmic during 
mitosis (Fig. 3.2D). The nuclei with mutant overexpression, especially R2510H, have a different 
morphology than WT full length or truncated SETD2-FLAG, being less round and having more 
patchy DNA and FLAG staining. This could be due to the genomic instability that both mutants 
confer when dominantly expressed in cells, either due to the lack of histone or tubulin methylation 
by these mutants. Together, the purification (Fig 3.1) and expression (Fig 3.2) experiments show 
that we have intact and properly-localizing protein to use in our biochemical experiments.  
 
 
 Fig. 3.1 Purification of ccRCC point mutations in tSETD2-FLAG A) Schematic of 
tSETD2-FLAG domain architecture highlighting the two main ccRCC mutations, R1625C 
in the SET domain (red) and R2510H in the SRI domain (purple). Previous in vivo studies 
show that R1625C rescues neither histone nor tubulin methylation, but R2510H mutation 
retains histone and loses tubulin methylation. B) Size exclusion chromatogram of both 
mutants purified from HEK293 cells. C) Mutants analyzed by Coomassie gel 
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The ability of the mutant tSETD2 proteins to carry out methyltransferase activity was tested 
in vitro by utilizing the methyltransferase assay described in Chapter 2. Briefly, this assay works 
by monitoring the production of SAH, the byproduct of SAM-dependent methyl transfer, using 
fluorescence and then correlating the time-dependent fluorescence traces directly to 
methyltransferase activity. Using WT tSETD2-FLAG as a control, both the tSETD2(R1625C)-
FLAG and tSETD2(R2510H)-FLAG mutant activities were tested with both histone H3 peptide 
(aa21-44) and porcine brain tubulin substrates. From the corrected fluorescence traces, the activity 
was calculated by determining the initial velocity using a linear fit over the first portion of the 
experiment. Compared to WT tSETD2-FLAG, tSETD2(R1625C)-FLAG had no methyltransferase 
activity with either tubulin protein or histone peptide substrate (Fig. 3.3A). This result was 
expected based on the literature (Hacker et al. 2016) as the R1625C mutation in the SET domain 
abolishes catalytic activity. For its histone substrate, this mutation within the catalytic domain is 
known to prevent proper positioning of a histone substrate with the methyl donor SAM in the 
binding pocket (Hacker et al. 2016). Compared to WT tSETD2-FLAG, tSETD2(R2510H)-FLAG 
shows no activity with tubulin but retains histone methylation, as expected (Hackler et al. 2016, 
Park et al. 2016). The fact that the R2510H mutation in the SRI domain does not abolish activity 
towards the histone peptide allows us to calculate Michaelis Menten kinetic values towards this 
substrate. Compared to WT tSETD2-FLAG, the R2510H mutant has a slightly higher vmax 
(9.49±1.255 vs 41±048 for the WT protein), a lower kcat (7.08±0.97 vs 9.41±0.84 for the WT 
protein), yet comparable KM (0.45±0.22 vs 0.45±0.32. for the WT protein) (Fig. 3.3B). This means 
that, despite a similar affinity for the H3 peptide, the R2510H mutant leads to a different turn-over 
rate than WT SETD2.  
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 Fig. 3.3 R2510H ccRCC 
mutant cannot bind or 
methylate tubulin. A) 
Methyltransferase activity of 
tSETD2-FLAG WT (black 
dots), R1625C (red dots), and 
R2510H (purple dots), against 
histone H3 peptide (white 
bars) and tubulin dimers (grey 
bars) at 5 uM substrate 
concentration. Each dot 
indicates the average of a 
single experiment and the bar 
represents the average±SD 
methyltransferase activity 
across n=4 experiments. B) 
Kinetic constants measured by 
varying substrate 
concentration and performing 
Michaelis-Menton analysis. 
C) Co-immunoprecipitation 
of tubulin protein with WT, 
R1625C, and R2510H 
tSETD2-FLAG. The input 
and anti-FLAG pellet (IP) 
fraction were blotted with 
antibodies against FLAG tag 
(top) and β-tubulin E7 
(bottom). D) Sedimentation 
assay of tSETD2-FLAG WT, 
R1625C, and R2510H with 
microtubules. The supernatant 
and pellet fractions were 
separate by SDS-PAGE and 
imaged by Coomassie gel. 
Proteins bound to 
microtubules are found in the 




We hypothesized that the reduction in tubulin methylation by the R2510 mutation in the 
SRI domain  could be due to reduced or abolished ability to bind the tubulin substrate. To test this, 
we performed pull-down assays to assess the interaction of WT, R1625C, and R2510H tSETD2-
FLAG proteins with tubulin. We found that both WT and the SET domain mutant R1625C bound 
to tubulin but that the SRI domain mutant R2510H abolished the ability to bind tubulin (Fig. 3.3C). 
Likewise, we performed a co-sedimentation assay to see if these mutants are able to bind 
microtubules. Here we found that both mutants have reduced ability to bind to microtubules, (Fig. 
3.3D). These results suggest that the ccRCC-associated mutation of R2510H in the SRI domain 
abolishes the ability of tSETD2-FLAG to bind to and methylate tubulin as a substrate.  
 
3.3.2 SRI of SETD2 domain important for tubulin binding 
So far, our work suggests that the SRI domain of tSETD2-FLAG is critical for interaction with 
tubulin as a substrate. Previous work demonstrated that protein-protein interactions between the 
SRI-domain of SETD2 and the highly phosphorylated C-terminal domain (CTD) repeat of RNA 
Pol II recruits SETD2 to chromatin during transcription (M. Li et al. 2005; Rebehmed et al. 2014). 
Performing a sequence alignment of all SRI-domains annotated in Pfam, we were able to identify 
highly conserved amino acids within the SRI domain (Fig. 3.4A). The structure shows that many 
conserved residues are hydrophobic and reside inside the core of the domain. We decided not to 
probe any of these hydrophobic residues because we hypothesized that disrupting these amino 
acids would drastically alter the fold of the domain. However, many residues along the outside of 
the helical bundle are not hydrophobic and are instead either positively charged or aromatic. 
Moreover, a handful of these residues are implicated in RNA Pol II binding. Previous structural 
studies using NMR took a purified human SRI domain and titrated peptides of the phosphorylated 
C-terminus of RNA Pol II and observed chemical shifts in residues V2483, F2505, K2506, R2510, 
and H2514 of the SRI domain (M. Li et al. 2005; Vojnic et al. 2006) (Fig. 3.4B). These shifts 
suggest that these residues undergo a conformational change upon RNA Pol II CTD binding. Our 
alignment coupled with previous NMR-based studies pointed to positions within the SRI domain 
we could probe to identify a mechanism between tubulin and RNA Pol II binding.  
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Fig. 3.4 The SRI domain of tSETD2 is critical for binding tubulin A) Sequence alignment 
of  SETD2 SRI domain residues across species. Orange residues are hydrophobic residues 
important for three-helix bundle packing, blue are basic residues, and red is the acidic residue. B) 
Sequence conservation mapped onto the NMR structure of human SETD2 with most conserved 
residues colored in red and least in blue. Conserved residues that are not part of the hydrophobic 
packing are labeled. C) Some of the most conserved residues across species in the SRI domain 
(V2483, F2505, K2506, and H2514) were mutated to alanine, or the SRI domain was deleted. 
These constructs were expressed and purified D-E) and analyzed by D) Coomassie and E) size 
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exclusion chromatography. F) Purified WT, delSRI, or mutant versions of tSETD2-FLAG bound 
to anti-FLAG beads were incubated with either tubulin protein or HEK293 lysate. The presence 
of tSETD2-FLAG variant, tubulin, and RNA Pol II in the bead pellet was analyzed by western 
blotting with antibodies to the FLAG tag, α-tubulin, and phosphorylated RNA Pol II, respectively. 
The far right-column shows the input for the reaction with WT tSETD2-FLAG. G) Quantification 
of RNA Pol II (wihte) and porcine brain tubulin (grey) co-pelleting with tSETD2-FLAG as a 
percentage of the input reaction. Each dot indicates the percent bound from one experiment and 
the bar represents the average±SD across n=3 experiments.  
 
We thus generated tSETD2-Flag variants with alanine mutations to V2483, F2505, K2506, R2510, 
and H2514. We also generated a construct lacking the SRI-domain (ΔSRI) as a control (Fig. 3.4C). 
The mutant and deletion variants of tSETD2-Flag were purified from mammalian cells as before 
and analyzed by Coomassie gel and size exclusion chromatography (Fig. 3.4D-E). We tested the 
ability of the purified mutant and deletion tSETD2-Flag proteins to bind to Pol II and tubulin using 
a co-immunoprecipitation assay (Fig. 3.4F-G). The tSETD2-Flag proteins bound to anti-FLAG 
beads were incubated with either porcine brain tubulin or HEK293 cell lysates containing 
endogenous RNA Pol II. As expected, deletion of the SRI domain (ΔSRI) abolished the ability of 
tSETD2-Flag to bind to both RNA Pol II and tubulin substrates. Interestingly, the SRI-domain 
mutants varied in their ability to bind to the two substrates. The V2483A mutant retained binding 
to both substrates, the F2505A retained tubulin but not Pol II binding, the R2510H mutant retained 
Pol II but not tubulin binding, and the K2506A and H2514A mutants lost the ability to bind to both 
tubulin and Pol II. These results indicate that the SRI domain is involved in substrate recognition 
and that distinct residues in the SRI domain contribute to recognition of different substrates.  
 
3.3.3 Actin binding mechanism distinct from tubulin 
Lastly, we were curious to see if the SRI-domain of SETD2 is also important for actin binding and 
methylation. When compared to WT tSETD2-FLAG, little difference was observed in the ability 
of R2510H tSETD2-FLAG to methylate actin (Fig. 3.5A-E). While. the WT and R2510H proteins 
show similar Km values toward actin, the Vmax for tSETD2(R2510H) is lower than for WT, 
suggesting that the kcat, or the turnover rate, is also lower for R2510H mutant. To assess binding, 
a co-immunoprecipitation assay with actin and different SRI-domain mutants of SETD2 showed 
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that there are no impairments in actin binding with any of the SRI-domain mutations (Fig. 3.5F). 
As such, actin binding and methylation do not depend on the SRI-domain. This suggests an 
alternative mechanism for actin binding and methylation that is distinct from tubulin or RNA Pol 
II binding and does not leverage the electrostatic interactions of the positively charged residues 
within the SRI-domain of SETD2.  
 
 
Fig. 3.5 The SRI domain of tSETD2-FLAG is not important for actin binding or methylation. 
A-B) Representative fluorescence traces of tSETD2-FLAG A) WT or B) R2510H with varying 
concentrations of actin. C-D) Michaelis-Menton kinetic plots of activity of tSETD2-FLAG C) WT 
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or D) R2510H. E) Kinetic constants calculated from C-D for WT and R2510H with actin substrate. 
E) Purified WT, delSRI, or mutant versions of tSETD2-FLAG bound to anti-FLAG beads were 
incubated with actin. The presence of tSETD2-FLAG variant and actin in the bead pellet was 
analyzed by western blotting with antibodies to the FLAG tag and actin, respectively. The far left-




3.4.1 Gotta keep ‘em regulated 
Work here shows that common ccRCC mutations in SETD2 tune binding and thus methylation of 
tubulin. In particular, mutations in the SRI domain alter binding for its tubulin and RNA Pol II 
binding partners, suggesting a regulation between tubulin and histone methylation substrates. 
Because positively-charged residues within the SRI domain are critical for tubulin binding, 
electrostatic interactions between the SRI domain and the negatively charged α-tubulin tail likely 
facilitate substrate recognition.  
Tubulin binding that requires a functional SRI-domain appears to contradict previous work 
suggesting that the SET domain is sufficient for tubulin binding (Park et al. 2016). These 
discrepancies could be due to the use of different constructs and expression systems, as well as 
differences in experimental protocols. The fact that the interaction of RNA Pol II is less sensitive 
Fig. 3.6 Model of tubulin 
methylation by tSETD2. The SRI 
domain (purple) recognizes the 
negatively-charged CTT of α-
tubulin (grey) and positions the 
SET domain (red) for methylation 
of α-tubulin at the K40 position.  
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than tubulin to the R2510H mutation may be related to the sequence and charge of these binding 
segments. Specifically, the CTD of Pol II contains 22 heptapeptide (YSPTSS) repeats, and is 
highly phosphorylated whereas  the CTT of α-tubulin contains a short sequence of negatively-
charged residues. Thus, the interaction between the SRI domain of SETD2 with RNA Pol II may 
better tolerate the R2510H mutation than the interaction of the SRI domain with α-tubulin. If so, 
caution should be taken when studying interactions with RNA Pol II CTD peptides containing 
fewer repeats which could produce different results than using full-length RNA Pol II. 
Nevertheless, these results provide strong support for the hypothesis that genomic instability in 
ccRCC can be driven by tubulin-dependent functions of SETD2 contributed by the SRI domain.  
         By mutagenesis of the SRI domain based on structural information in the literature (M. Li 
et al. 2005; Kizer et al. 2005), we were able to identify residues that further distinguish the ability 
of SETD2 to bind to tubulin versus Pol II. We demonstrate that the ability of tSETD2 to bind to 
tubulin requires not only the SRI domain residue R2510, but also K2506 and H2514. In contrast, 
the ability of tSETD2 to bind Pol II is influenced by F2505, K2506, and H2514. These results are 
largely consistent with previous studies using NMR structures of the SRI domain and titration 
experiments with phosphorylated Pol II peptides that implicated residues V2483, F2505, K2506, 
R2510, H2514 in forming part of the SRI-Pol II binding interface (M. Li et al. 2005; Vojnic et al. 
2006; Rebehmed et al. 2014). However, while the isolated SRI domain with the R2510H point 
mutant showed decreased binding to RNA Pol II CTD peptides (M. Li et al. 2005), our results 
suggest that R2510H does not decrease the ability of tSETD2-FLAG to pull-down Pol II from cell 
lysates (Fig. 5C). These differences are likely due to differences in experimental conditions 
including the use of an isolated SRI domain versus tSETD2 and the use of Pol II peptides versus 
full-length CTD.  
 Our findings show that the positively-charged residues within the SRI domain make 
electrostatic interactions with the negatively-charged CTT of α-tubulin. Because the CTT of 
tubulins are often modified, tubulin PTMs could change substrate recognition. Especially 
polyglutamylation would add significantly more negative charge to the CTT and as such could 
increase binding affinity. Future work will have to look at the fine tuning of the SRI-domain as a 
tubulin PTM reader and how other modifications alter or crosstalk with methylation by SETD2. 
In addition, more work needs to be done to understand how mutations in the SRI impact histone 
methylation. We and others observed that methylation of histone peptides are also impacted by 
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SRI-domain mutations despite reactions lacking RNA-Pol II. As such, we suspect that there could 
be other histone-mediated interactions that could be required for proper H3K36 methylation by 
SETD2.  
 
3.4.2 Role of cytoskeleton in cancer pathologies 
Our findings provide further support for a role of SETD2 in writing the histone, tubulin, and actin 
codes. Here, we verified the in vivo studies (Hacker et al. 2016; Park et al. 2016) looking at two 
main kidney cancer mutations in SETD2, R1625C and R2510H, and found that both mutations 
abolish the ability of SETD2 to methylate tubulin. With binding assays, we expanded this model 
and found that the R2510H mutation cannot bind tubulin, thus launching an investigation whether 
the SRI domain regulates methylation by SETD2. As mutations in SETD2 continue to be identified 
in a growing list of tumor types (J. Li, Duns, Westers, Sijmons, van den Berg, et al. 2016; Chiang 
et al. 2018), it will be important to discern the relative roles of histone versus tubulin methylation 
in contributing to the underlying mechanisms of particular cancer phenotypes. A better 
understanding between histone, tubulin, and actin methylation by SETD2 could also drive anti-
cancer drug development and thus could provide new therapeutic targets to help cancer patients.   
Some of the SRI domain mutations we made probing RNA Pol II and tubulin binding are 
also found in other types of cancer. For example, the missense mutation of F2505L is found in 
patients with acute leukemia (Zhu et al. 2014), and blocks binding of SETD2 to RNA Pol II, and 
as such loses H3K36me3 (M. Li et al. 2005; Rebehmed et al. 2014). In general, similar missense 
mutations in SETD2 account for ~10% of genetic abnormalities of leukemia patients, though the 
mechanism of many of these mutations remains unclear since some do not impact histone 
methylation. Additionally, truncation mutations, K2469 and V2516, have also been identified in 
ccRCC patients, though similarly the mechanism remains unknown (Network 2013). These studies 
suggest that other residues within the SRI-domain may play a role in substrate recognition. Our 
data suggest that cytoskeletal methylation, in particular tubulin modifications, should be studied 
to understand leukemia- and kidney cancer-driving pathologies.  
Other tubulin code factors beyond tubulin methylation have been shown to impact mitotic 
progression and may also underlie cancer phenotypes. A disruption of α-tubulin detyrosination 
leads to reduced chromosome congression and increased errors of kinetochore-microtubule 
attachment (Peris et al. 2009; Barisic et al. 2015; Liao et al. 2019; Ferreira et al. 2020). Moreover, 
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deregulation of the detyrosination-tyrosination cycle influences tumorigenesis (Mialhe et al. 2001; 
Kato et al. 2004; Souček et al. 2006). Additionally, tubulin glutamylation changes throughout the 
cell cycle, where levels increase during mitosis on both centriole and spindle microtubules, 
especially kinetochore microtubules (Bobinnec et al. 1998). The combination of detyrosination 
and polyglutamylation, mediated through septin, are important to recruit microtubule associated 
proteins to the microtubule lattice, where the inhibition of tyrosination and polyglutamylation leads 
to taxane-resistance (Froidevaux-Klipfel et al. 2015). With taxanes, like Taxol® commonly used 
in cancer treatment, these studies suggest a fine-tuning of tubulin modifications that can drive 
drug-resistant tumors in cancer patients. In addition to chemical modifications, tubulin isotypes 
also play a role in cancer, where an increase or decrease in expression levels of particular β-tubulin 
isotypes correlate to specific tumor types (Parker et al. 2017). For example, increased expression 
of Tubβ3 is implicated in lung, ovarian, breast, gastric, and prostate cancers and has a poor 
response to taxane treatment due to emerged drug resistance (Kavallaris, Burkhart, and Horwitz 
1999; Hari et al. 2003; Akasaka et al. 2009; McCarroll et al. 2015). Further investigations into 
tubulin PTMs and their modifying enzymes are required to understand the nuanced interaction 
tubulin writers and readers and their implications for cancer progression.  
Our findings showed that actin at lysine 68 can also be methylated by SETD2, and the lack 
of actin methylation impairs actin dynamics at the cell periphery. Similarly, arginine methylation 
of H73 of actin by SETD3 also is associated with actin polymerization (Nyman et al. 2002). Actin 
plays a significant role in cancer because oftentimes cancer cells are extremely motile (Yamaguchi, 
Wyckoff, and Condeelis 2005; Condeelis, Singer, and Segall 2005). As such, actin in cancer cells 
are typically more dynamic and have distinct cytoskeletal reorganization compared to non-cancer 
cells, contributing to metastasis. Compared with our findings that actin dynamics decrease without 
methylation, it suggests a disease-driving mechanism distinct from highly motile cells. That said, 
we found that actin methylation depends on HTT and the actin-binding protein HIP1R. HTT 
associates with SETD2 alters methylation activity by sequestration of the methyltransferase 
(Passani et al. 2000; Gao et al. 2014) in neurons, which also may have implications in Huntington’s 
Disease since mutant HTT could promote abnormal interactions with other proteins. Additionally, 
HTT, SETD2, and actin can all localize in the nucleus, and nuclear actin regulates transcription 
and DNA repair (Hyrskyluoto and Vartiainen 2020). As such, SETD2, HTT, and actin could 
interact within the nucleus to additionally regulate cellular processes. However, without a better 
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understanding of how these proteins associate and bind, regulation of SETD2 methylation of actin 
remains unknown. 
 
3.5 Materials & Methods 
Plasmids. 
An active truncated SETD2 construct (1418-2564) with a FLAG affinity tag (tSETD2-FLAG) for 
mammalian pInducer expression was gifted by the Walker Lab. Single isoform αTub1B/βTub3 
plasmid was obtained from the Kapoor lab for insect cell expression (Ti, Wieczorek, and Kapoor 
2020). Point mutations and domain deletions were generated using QuickChange site-directed 
mutagenesis with Q5 Polymerase (NEB). All plasmids were verified by DNA sequencing.  
 
Purification.  
SETD2. tSETD2-FLAG and all its variants was purified as described in Chapter 2.  
αTub1B/βTub3 tubulin. Single isotype tubulin, in addition to the tail-less tubulin, was purified as 
described in Chapter 2.  
 
Methyltransferase assay.  
Activity of tSETD2-Flag constructs was surveyed using a Methyltransferase Fluorescence Assay 
Kit (Cayman Chemical, 700150) as described in Chapter 2.  
 
Immunohistochemistry.  
COS7 cells transiently expressing tSETD2-FLAG constructs were imaged as described in Chapter 
2.  
 
Microtubule polymerization.  
GMPCPP-stabilized.  αTub1B/βTub3 microtubules were prepared as described in Chapter 2.  
 
Pull-down assay. FLAG M2 beads were blocked with 3% BSA in PBS for 1 hour and equilibrated 
in the reaction buffer (tSETD2-Flag size-exclusion buffer, described previously). tSETD2-Flag 
protein (WT or variants) was added at 20 μM with a putative binding partner for 2 hours in the 
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presence of SAM. For tubulin, 0.25 mg/mL of porcine tubulin (Cytoskeleton, Inc.) was used, for 
actin, 0.25 mg/mL of rabbit actin (Cytoskeleton, Inc. AKL99) was used, and for RNA Polymerase 
II, 10 μL of HEK293 Freestyle clarified lysate was used. Beads were spun down and the 
supernatant was collected as the fraction of unbound substrate. The beads were then resuspended 
in the reaction buffer to the total reaction volume, and the same amount of supernatant and beads 
were added to SDS-PAGE gel. Analysis of binding was conducted by western blot with the 
following antibodies: anti-FLAG (Sigma Aldrich, A9469, 1:1000), anti-tubulin antibodies E7 
(DSHB, AB_528499, 1:1000) and/or TU-01 (Abcam, ab7750, 1:1000), anti-RNA Polymerase II 
(Abcam, ab193468, 1:1000), and anti-actin (Fisher Scientific, MS1295P0), with secondary 
antibody anti-mouse (Enzo Life Science, ADI-SAB-100-J, 1:1000) or anti-rabbit (Enzo Life 
Science, ADI-SAB-300-J, 1:1000), respectively. Binding was quantified by measuring the 
background-subtracted intensity of each band with Fiji ImageJ (Schindelin et al. 2012) as a fraction 
of the input intensity. Each experiment was performed three times, independently.   
 
Sedimentation. Microtubules were polymerized by incubating 2.5 mg/mL porcine brain tubulin 
(Cyotskeleton Inc, #) with 0.1 mM GTP and 0.2 mM MgCl2 in BRB80 buffer and incubated at 
37C for one hour. These microtubules were taxol stabilized by adding 100 uL of 2 mM taxol in 
BRB80 buffer and incubating at 37C for 30 minutes. Taxol stabilized microtubules were spun 
down at 15K rpm at room temperature for 10 minutes, before incubating with 5 uM tSETD2-
FLAG. Reactions were incubated for one hour at room temperature, before 100 uL of cushion 
buffer, 2 mM taxol with 60% glycerol in BRB80, was added and the reaction was centrifuged at 
100K xg at room temperature for 40 minutes. The uppermost layer of the supernatant was removed 
and the pellet was resuspended in 50 uL of 2uM taxol BRB80 buffer. Supernatant and pellet of 
each reaction was analyzed by Coomassie gel electrophoresis.  
 
Sequence alignment. All SRI-domain containing proteins identified in Pfam (Finn et al. 2014) 
were aligned using Clustal Omega (Sievers and Higgins 2018). Alignments were imported into 
Chimera (Yang et al. 2012) and mapped onto the NMR structure of the human SETD2 SRI domain 
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Chapter 4: Future Directions 
4.1 Structure of tubulin with SETD2 
My data shows first and foremost that the histone lysine methyltransferase SETD2 has a wider 
substrate scope than just histones and can modify cytoskeletal elements tubulin and actin in vitro. 
For tubulin methylation, I found that positive residues on the SRI domain of SETD2 make 
electrostatic interactions with a-tubulin CTT. This allows the SET domain to wrap around tubulin 
and methylate the aK40 site. SETD2 is able to methylate both tubulin dimers in solution in addition 
to microtubule polymers but has higher activity with the former. For actin methylation, we found 
that SETD2 methylates K68, which is accessible in both monomer and filamentous actin 
populations, and as such can methylate both with equal activity. Our cartoon model of tubulin 
methylation by SETD2 accurately summarizes what our studies have found (Fig. 3.6), but it 
certainly lacks high resolution data. Further understanding into how the SRI domain binds tubulin, 
or how the SET domain interacts with the K40 loop of α-tubulin, requires higher resolution 
information about the structure. Due to the high flexibility and large size of the tubulin-tSETD2 
complex, we would turn to cryoEM and perform single particle analysis. 
When considering the microtubule and tubulin dimer substrates of SETD2, my data 
suggests that the tSETD2-tubulin dimer complex (Fig. 4.1A) is likely to be a better structural target 
based on activity and binding assays. However, a small amount of tSETD2-FLAG remains in 
complex with tubulin when performing size exclusion chromatography (Fig. 4.1B), and moreover 
this complex dissociates or aggregates on cryoEM grids (Fig. 4.1C). tSETD2-FLAG itself also has 
a lot of flexibility and the domains that have structural features are too small compared to the 
whole protein to be able to find particles. To try and get a structure of tSETD2, with or without 
tubulin, crosslinkers may have to be used to stabilize the structure. By exposing macromolecular 
complexes to a low concentration of chemical cross-linkers during sedimentation, the gradient 
fixation (GraFix) can stabilize individual particles (Kastner et al. 2008; Stark 2010). During the 
cross-linking process, covalent bonds are formed between functional groups, thus making the 
protein complex less flexible and more stable. Centrifuging helps prevent aggregation and 
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precipitation due to the increased pressure during the hard spin. To use GraFix on the tSETD2-
tubulin structure, the chemical cross-linker and buffer would have to be optimized, in addition to 
any glycerol removal before grid application. But optimization of parameters could result in a 
stable complex which would help obtain the structure of tubulin with SETD2. In addition, because 
full length SETD2 is autoinhibited, and not to mention much larger, crosslinking may be able to 
stabilize the autoinhibited protein.  
One thing that would be helpful is knowing the structure of the tubulin dimer. Historically, 
the tubulin dimer structure has been difficult to solve due to its small size of ~100 kDa. In the late 
1990s, a structure of the tubulin dimer within the lattice was determined using electron 
crystallography, where the addition of zinc ions induced anti-parallel protofilaments sheets 
(Nogales, Wolf, and Downing 1998). This resulted in a 3.7 Å model, a feat at the time but not 
useful in answering questions about tubulin dimer state in solution. More recent microscopy and 
structural studies have looked at tubulin dimers within the microtubule lattice using cryoEM, for 
example identifying the motor binding site and longitudinal contacts within the lattice (Arnal et al. 
1996; Nogales et al. 1999; Meurer-Grob, Kasparian, and Wade 2001). With the “resolution 
revolution” and better data processing software and pipelines, more details can be observed in the 
lattice structure, for example how nucleotide state, tubulin isotypes, protein binding, and small 
molecules impact the lattice (Li et al. 2002; Alushin et al. 2014; Zhang et al. 2015; Kellogg et al. 
2017; Zhang, LaFrance, and Nogales 2018; Kellogg et al. 2018; Ti, Alushin, and Kapoor 2018). 
Despite the advances and detail into the microtubule polymer, the tubulin dimer structure remains 
unknown. Some recent work has looked at tubulin oligomers, and found that straight oligomers 
promote nucleation and polymerization of microtubules (Ayukawa et al. 2020). However, the 
mechanism of plus-end growth of microtubules has been contested (McIntosh et al. 2018; 
Mickolajczyk et al. 2019). Knowing the conformation of tubulin dimers in solution (straight or 
bent, elongated or compact) will make clear the role of nucleotide state on polymerization, and 
how proteins interacting with dimers alters polymerization dynamics at a structural level. 
 Our preliminary studies looking at just tubulin dimers have focused on sample preparation, 
because, to our knowledge, this structure has not been attempted since better detectors were 
developed. Because porcine tubulin in a microtubule buffer contains high background and either 
promotes aggregation (Fig. 4.1E) or polymerization (Fig. 4.1F), we turned to a recombinant yeast 
tubulin that contains mutations in β-tubulin that block polymerization (Johnson et al. 2011) (Fig. 
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4.1G). We collected a full dataset of yeast tubulin on gold grids (Fig. 4.1H-I), combining tilted and 
untitled micrographs in the attempt to overcome preferred orientation. However, we were unable 
to overcome preferred orientation during data processing and were stuck at an ~10 Å map. 
Switching to carbon grids, we were able to obtain more side views of the tubulin dimer (Fig. 4.1J-
K). From this half-day of screening, we were able to obtain an 6.7 Å map using particles picked 
by Warp (Tegunov and Cramer 2019) and processed in cryoSPARC (Punjani et al. 2017) (Fig. 
4.1L). Molecular docking of previously solved tubulin structure (pdbid: 1tub, Fig. 4.1M) suggests 
that our dimer structure has a straight and uncompressed conformation. However, more work will 
need to be done to get this structure to high resolution, perhaps through more data collection or 
better particle picking. Limitations so far have been preferred orientation and thick ice on the grid, 
so different grids, such as graphene oxide, could be used to obtain thin ice and overcome preferred 
particle orientation. 
 If we had the structures of both tubulin dimers and the SETD2-tubulin complex, we would 
be able to more specifically identify how the SRI-domain of SETD2 recognizes and binds to 
tubulin in addition to finding other domains that are important for substrate recognition. While 
studies have shown the WW domain flanking the SRI-domain is important for autoinhibition of 
full length SETD2, it could be the case that the WW domain plays other roles in protein-protein 
interactions with tubulin (or other substrates). Seeing the structure of SETD2 bound to substrate 
would show us what other domains are important for tubulin binding and methylation. Moreover, 
SETD2 bound to actin would allow us to elucidate how these proteins interact because our 
biochemical data so far has shown us negative results. Comparing structures of SETD2 with 
different substrates would highlight the nuanced difference in substrate specificity and recognition. 
Because histone, tubulin, and actin methylation all have different outcomes in the cell, fine-tuning 
the structure through small molecule drugs could alter activity specifically. As such, a structure of 





Fig. 4.1 Efforts into getting the tubulin dimer structure. A-C) tSETD2-FLAG in complex 
with tubulin A) schematic B) size-exclusion chromatography of the tSETD2-FLAG complex 
C) micrograph of complex aggregated on a grid. D-F) Single isotype tubulin D) schematic E) 
aggregation on a grid F) oligomer formation on a grid G-K) yeast tubulin with β-tubulin 
mutations that block polymerization G) schematic, β-tubulin in red to signify mutation H) gold 
grid at hole level I) micrograph at exposure level of preferred orientation particles on gold grid 
J) carbon grid at the hole level K) micrograph at exposure level of particles on carbon grid L) 
Subset of 2D classes M) 3D refinement with tubulin dimer docked.  
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4.2 Image tubulin methylation on mitotic spindles 
In addition to obtaining the structure of tSETD2-FLAG with tubulin dimer, we would want to 
further observe the enzyme’s localization in cells. Our studies show that tSETD2-FLAG is 
dispersed throughout the cytoplasm during mitosis, but when and how it specifically goes to the 
centrioles to methylate tubulin in growing mitotic spindles remains unclear. Moreover, how 
methylated tubulin is incorporated into the mitotic spindle, and when and how the mark is removed 
upon successful cell division, is also unknown. Recent advances in imaging techniques could 
answer some of these questions. Due to the dynamic nature of the spindle, light microscopy has 
remained to be the main tool to observe the microtubules involved in cell division (Maddox et al. 
2012). Fluorescence imaging adds specificity to the molecules being observed. Thus far, 
immunofluorescence imaging has shown co-localization of methylation and tubulin at the minus 
ends of the mitotic spindle during cell division.  
Visualizing the mark using antibodies has thus far been difficult because the modification 
is temporal in the cell and thus difficult to isolate in addition to being low in abundance. Moreover, 
a limitation of immunofluorescence imaging of methylated tubulin is the lack of a specific 
antibody that recognizes tubulin methylation specifically rather than methylation in general (Park 
et al. 2016; Chiang et al. 2018). As such, we need to develop an antibody that has an epitope 
against methylated tubulin. Once we have a specific antibody for methylated tubulin, we could 
perform experiments that allow us to image cells and tubulin methylation directly without other 
methylation signals. Fluorescent imaging with cells (over-) expressing tSETD2-FLAG could be 
coupled and imaged with antibodies for both FLAG and methylated tubulin. These cells would be 
synchronized and then fixed to monitor across a cell cycle where SETD2 and methylated tubulin 
are during interphase and mitosis.  
Moreover, we could combine fluorescence microscopy with electron microscopy using 
correlative light electron microscopy (CLEM) and cryo-electron tomography (cryoET), the 
combination cryoCLEM. By combining whole cell visualization of individual fluorescent proteins 
in living cells, with spatial imaging of that same cell frozen in its native environment (Plitzko, 
Rigort, and Leis 2009; Schwartz 2008). Because cryoET is limited to a sample thickness of under 
500 um, thinner than most cells, samples typically must be prepared using focused-ion-beam (FIB) 
milling (Villa et al. 2013). While CLEM can help identify where to FIB mill, the procedure and 
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protocols are extremely challenging. Attempting to image a mitotic cell, as such, would provide 
an even bigger challenge even when CLEM highlights where to make the “windows into the cell.” 
Nevertheless, as protocols for FIB-milling and cryoET become more common, the structure of 
methylated tubulin by SETD2 on the mitotic spindle could be determined, along with many other 
interesting cell-division-based structures like the kinetochore.  
4.3 Regulation of SETD2  
SETD2 methylates histones, tubulin, and actin, but outstanding is how this 
methyltransferase is regulated and localized for it to modify its various substrates. Our 
collaborators have identified SETD2 in the cytoplasm even during interphase (Seervai et al. 2020), 
but how it gets there without being degraded or transported back into the nucleus remains a 
mystery. Additionally, how SETD2 seems to methylate actin during interphase in sufficient 
quantities to alter cell migration, yet not methylate tubulin while it’s cytosolic, is also unknown. 
More work doing live cell imaging will show us where and how SETD2 gets to the cell periphery 
to methylate actin, the minus ends of microtubules to methylate tubulin, and the nucleus to 
methylate histones during transcription. Imaging alone, however, only shows us where SETD2 is 
localized, rather than actually carrying out methyltransferase activity. As such, cells expressing 
SETD2 could be synchronized and fixed at different time points during mitosis and re-entering 
interphase, then stained with DAPI, FLAG, tubulin, and general methylation antibodies to 
correlate where SETD2 is with methyltransferase activity. We would expect that during mitosis 
SETD2 would localize to the centrioles and we would observe an increase in methylation signal 
in the cytoplasm surrounding the centrioles, and then have the methylation signal become 
incorporated into the mitotic spindle. After cell division, we would try and observe where SETD2 
goes and if any methylation signal increases near the cell periphery. These types of time course 
imaging experiments would help us see how and where SETD2 goes in the cell to methylate its 
various substrates.  
Given our findings that tubulin methylation is found on the inside of the microtubule, and 
that tSETD2-FLAG can methylate microtubules, another outstanding question is how SETD2 
accesses the K40 loop despite it being a large protein. Chapter 2 discussed two possible 
mechanisms: either the enzyme can enter the lumen like the tubulin acetyltransferase, αTAT, or it 
enters the lumen through lattice defects. Microtubule lattice self-repair in structurally damaged 
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sites, for example where microtubules cross each other or have been damaged by other proteins, 
is responsible for the rescue of microtubule growth (Aumeier et al. 2016). This model is supported 
by the observation of  “GTP islands” that are detected in microtubule lattices, far from 
polymerizing ends, where GTP-tubulin is incorporated in otherwise GDP-tubulin lattice (Dimitrov 
et al. 2008; de Forges et al. 2016; Bollinger et al. 2020). However, whether and how modifying 
enzymes like SETD2 enzymatically alter tubulin before, during, or after microtubule rescue 
remains unknown. We could try and figure this out by fixing distressed microtubules and staining 
for FLAG, methylation, and GTP tubulin. Perhaps this experiment could determine when and 
where tSETD2-FLAG is and whether or not it methylates at areas of distorted and broken 
microtubule lattice. We anticipate that, while SETD2 may methyate microtubules at these exposed 
areas, this would not be terribly relevant in the context of the mitotic spindle.  
Additionally, SETD2 is highly regulated by a number of other proteins.  RNA Pol II, along 
with Iws1, and Spt6 are critical for proper histone 3 lysine 36 methylation (Yoh, Lucas, and Jones 
2008; Rebehmed et al. 2014), and Huntington protein (HTT) along with the actin-binding adapter 
HIP1R in complex with SETD2 regulate actin methylation (Seervai et al. 2020). More work needs 
to be done to identify whether and which proteins mediate tubulin methylation in cells. This could 
be done using BioID, a screening method to identify protein-protein interactions that occur in 
living cells (Roux, Kim, and Burke 2013; Sears, May, and Roux 2019). By tethering a promiscuous 
biotin ligase to tSETD2, expression in cells leads to biotinylation of interacting and proximal 
proteins. Then, the biotinylated proteins can then be purified using affinity beads and identified 
with mass spectrometry. Using our different tSETD2 mutants described in Chapter 3, differences 
in protein-protein interactions could be teased apart and could hint at methylation regulation in 
cells. A similar experiment could be conducted with synchronized cells to identify differential 
interactions in mitotic and interphase cells, perhaps also determining a mechanism for how SETD2 
remains cytoplasmic during interphase. These experiments could also be conducted using the full 
length SETD2, which is autoinhibited. Performing BioID and comparing binding partners between 
truncated and full length SETD2 may play a role in substrate binding and activation of the enzyme. 
Moreover, identifying binding partners throughout the cell cycle could pose more questions and 
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Appendix A1: Cilia maintenance by KIF3A/KIF3B 
A.1 Forward 
 
This chapter will introduce some adjacent work I’ve conducted researching kinesin motors in 
primary cilia. Some of this work was published in Engelke, et al. (2019) Current Biology with 
then-postdoctoral fellow Martin Engelke leading the project in collaboration with Dr. Benjamin 
Allen’s lab.  
A.2 Introduction 
Imagine yourself as a bird flying above a suburban city. You’d see cars driving towards and away 
the city center, bike trails through the forest, and pedestrians walking along sidewalks and paths. 
Farther away, perhaps you hear the interstate highway system, with cars and trucks zooming to get 
to their destination. Much like this little city, each cell in our body has a similar network of 
structural elements used for transportation called the cytoskeleton. Microtubules and actin fibers 
work together to form this cytoskeleton, where the former are for long-range transport like 
highways and the latter are more like local side streets. Depending on the type of road, there are 
particular molecular vehicles and pedestrians that transport intracellular cargo. These different 
roads have distinct motor proteins that “walk” on them in a processive foot-over-foot manner: 
myosin motors move along actin fibers and kinesin and dynein motors on microtubules. 
On the microtubules, kinesin motors are largely responsible for anterograde transport to 
the cell periphery and dynein motors perform retrograde transport back to the cell center (R. Vale, 
 
1 The following appendices highlight some work I’ve been a part of beyond my main thesis work 
surrounding the narrative of cytoskeletal methylation. Appendix A discusses work I conducted during my 
rotation in the Verhey lab, and Appendix B shows a combination of cryoEM data collection and processing 
techniques in the Cianfrocco lab.  
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Reese, and Sheetz 1985; Gibbons and Rowe 1965; R. D. Vale, Soll, and Gibbons 1989). Focusing 
here on the kinesin superfamily of proteins (a.k.a. KIFs), kinesin motors are divided up into 15 
families based on phylogenetic analyses (Lawrence et al. 2004; Hirokawa and Takemura 2004). 
In general, in terms of domain architecture, kinesins have an N-terminal motor ATPase domain 
and dimerize with a coil-coiled stalk. There are some cases of a C-terminal motor domain that 
move in the opposite, or minus-end, direction and some motors with a central domain destabilize 
microtubules rather than move along their surface. There are also some cases of single-headed 
kinesin motors carrying cargo in teams (Schimert et al. 2019). Typically functioning as dimers 
however, kinesin enzymes use the energy-providing molecule ATP to generate power to walk on 
microtubules. This nucleotide binds in the ATPase domain of kinesin and then converts the 
chemical energy of ATP hydrolysis to ADP into mechanical energy and force production. 
Additionally, a flexible 12-18 amino acid sequence called the neck linker (NL) adjacent to the 
ATPase domain serves as a structural element for force generation and directed motility. With the 
addition of ATP, the NL docks and the rear motor head will swing forward, where subsequent 
ATP hydrolysis will complete NL docking and induces microtubule binding by the other motor 
head (Shang et al. 2014; Phillips et al. 2016; Budaitis et al. 2019). At this stage, kinesin will either 
complete a mechanical step by binding to the next microtubule site and releasing ADP, or will fall 
off the microtubule if it prematurely releases phosphate (Milic et al. 2014).  
The diversity across these different kinesin motors is indicative of their various roles 
throughout the cell depending on the family. For example, kinesin-1 motors are important for 
vesicle, organelle, and mRNA transport, kinesin-2 for intraflagellar transport in cilia, and kinesin-
4 and -5 for chromosome positioning and spindle pole separation in mitosis. How the many 
different kinesin motors are regulated depends on many factors including activation, cargo 
adaptors, and cell cycle state. To prevent needless ATP hydrolysis and clear up space on crowded 
microtubules, motor activity must be deactivated where kinesin is regulated by auto-inhibition 
(Hammond et al. 2010; Kaan, Hackney, and Kozielski 2011; Ren et al. 2018). Such folding 
requires hinge sections within the coil-coil domain, where the C-terminal cargo adaptor interacts 
with the N-terminal motor. With kinesin-1 as the canonical kinesin as an example, the QIAKPIRP-
containing tail domain directly contacts a helix in the motor domain that acts like a switch to 
prevent ADP release from the nucleotide pocket (Dietrich et al. 2008; Verhey and Hammond 
2009). Cargo binding can subsequently activate kinesin motors for microtubule-based transport. 
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For example, fasciculation and elongation protein-ζ1 (FEZ1) and Jun N-terminal kinase interacting 
protein (JIP1) are required in cells to bind to the inhibitory regions of the molecule for activation, 
KHC tail and the KLC, respectively (Blasius et al. 2007). Adding complexity, the cargo adaptor 
that activates kinesins depends on the motor, the cargo itself, and the presence of adaptor or 
scaffold proteins (Hirokawa et al. 2009). 
 
Cilia formation and maintenance by kinesin-2 motors 
Cilia are microtubule-based organelles that protrude from the surface of almost every 
human cell. Cilia consist of a core called the axoneme, which is constructed from nine parallel 
doublet microtubules (A- and B-tubules) that project from a basal body and is surrounded by a 
specialized ciliary membrane which is an extension of the plasma membrane. Particular types of 
cells have distinct ciliary functions like a sperm’s flagellar tail, or the respiratory tract’s cilia that 
helps move liquids over the surface of organs. Both of these examples are of motile cilia. Primary 
cilia, on the other hand, are largely immotile and instead function as cellular antennae to sense 
extracellular stimuli. For example, vertebrate Hedgehog (Hh) signaling depends on the presence 
of a primary cilium for proper gene transcription. Given this critical role particularly for 
development, incorrect ciliary formation gives rides to a collection of diseases, termed ciliopathies, 
like midline defects, neural tube defects, polydactyly, and lung hypoplasia (Wheway, Nazlamova, 
and Hancock 2018). 
Cilium biogenesis requires a process of cargo transport to the tip and back down to the 
basal body, called intraflagellar transport (IFT). Motor proteins, particularly kinesin-2 and dynein-
2, are responsible for antero- and retro-grade transport, respectively, of multiprotein complexes 
called IFT trains. These protein assemblies are divided into A and B complexes (which have six 
and sixteen proteins) and deliver axoneme precursors to the site of incorporation at the axoneme 
tip and could be rearranged themselves. These IFT train complexes also contribute to ciliary 
maintenance by carrying cargo, like free tubulin, to be incorporated into the axoneme (Craft et al. 
2015; Lechtreck et al. 2017). With regard to ciliary-cell signaling pathways, like Hedgehog 
signaling, IFT trains are also thought to move membrane-associated signaling complexes (Wang, 
Pan, and Snell 2006). Anterograde transport of IFT trains occurs predominately on B-tubules and 
retrograde transport on A-tubules, perhaps to avoid collisions in a very busy and compact organelle 
(Kuhns and Blacque 2016; Prevo, Scholey, and Peterman 2017; Bertiaux et al. 2018; Webb, 
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Models of IFT had been based on invertebrate model systems such as C. elegans and 
Chlamydomonas. However, these organisms are inadequate to describe mammalian functions due 
to both inconsistencies and a lack of homologs: Klp20/Kpl11/Kap is required in Chlamydomonas, 
but not in C. elegans, OSM-3 is required in C. elegans, but not in Chlamydomonas and the 
homolog KIF17 in mice seems dispensable. Instead, knock-outs of kinesin-2 heterodimeric protein 
KIF3A/KIF3B in mouse models are lethal due to a lack of cilia formation. Given that knock-down 
or -out approaches lead to off-target effects, to understand how mammalian cilia formation and 
maintenance occurs, a post-doc in Verhey lab used a chemical-genetic strategy to engineer an 
inhibitable version of this heterodimeric protein (Engelke et al. 2016). This strategy fused a DmrB 
domain, and a short linker, to the N-terminal motor domains of KIF3A and KIF3B such that when 
a small molecule B/B homodimerizer (B/B) is added the kinesin motor can no longer take a step 
forward, much like tying someone’s sneaker shoelaces together (Fig. A1). In addition, a 
KIF3A/KIF3B CRISPR-Cas9 knock-out cell line in NIH-3T3 cells was generated. Typically, NIH-
3T3 cells generate primary cilia which we observed by immunofluorescence staining for ciliary 
marker ARL13B. In double knockout KIF3A-/- KIF3B-/- cells, primary cilia only form when 
KIF3A and KIF3B are transiently expressed. When the inhibitable constructs are transfected, cells 
Figure A1. Inhibitable kinesin-2 
motor, KIF3A/KIF3B. Left: 
endogenous heterotrimeric 
KIF3A/KIF3B/KAP. Middle: 
Engineered inhibitable motor with 
DmrB domains (orange) on the N-
terminus of KIF3A and KIF3B 
(iKIF3A/iKIF3B). Right: inhibitable 
motor with small molecule inhibitor 
B/B homodimerizer (B/B, red) 
yielding an immotile motor.  
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are also able to generate primary cilia, but when the B/B inhibitor is added, cilia are absent (Fig. 
A2). The combination of double-knockout cells and an inhabitable iKIF3A/iKIF3B allowed us to 
probe and monitor cilia maintenance and disassembly processes.  
 
 
A.3.2 Kinesin-2 KIF3A/3B is necessary for cilia formation and maintenance 
We hypothesized that KIF3A/3B are responsible for ciliary maintenance because they carry 
IFT trains within the cilia. To understand the role of kinesin-2 motors, we expressed iKIF3A-
Figure A2. Kinesin-2 
KIF3A/KIF3B 
necessary to form 
cilia. A) In NIH3T3 
cells with vehicle 
mCherry vector, have 
proper cilia formation 
as determined by ciliary 
marker ARL13B. B) In 
KIF3A/KIF3B 
CRISPR-Cas knock 
down cell line, left: 
there is no cilia 
formation, right: 
transfecting in WT 
KIF3A/KIF3B rescues 
cilia formation in 
transfected cells. C) 
Inhibitable motor left: 
recuse cilia formation, 
right: when inhibited 
with B/B, cilia do not 
form. Experiments 




neonGreen and iKIF3B-mCherry in the double knockout cells and allowed them to generate 
primary cilia. Two days after transfection, we added B/B inhibitor at different times to measure 
the impact of inhibited KIF3A/3B over a time course (Fig. A3A). These cells were fixed and 
stained with antibodies against axonemal marker acetylated ɑ-tubulin and the ciliary membrane 
marker Arl13B. Treatment with B/B inhibitor resulted in a decrease in the percentage of cells that 
contained a primary cilium as early as 1 hour after treatment, and the percentage of ciliated cells 
continued to decrease over the next 8 hours of experimentation (Fig. A3B). A similar, albeit less 
dramatic, trend was also seen in the length of the cilia. As KIF3A/KIF3B inhibition results in a 
decrease in the percentage of ciliated cells over time, the cilium length measurements at a later 
point are based on only a few cilia (Fig A3C). Taken together, these data suggest that inhibiting 
kinesin-2 KIF3A/3B contributes to the disassembly of primary cilia, thus suggesting that 






Figure A3. Inhibiting 
iKIF3A/iKIF3B 
reduces the number 
and length of ciliated 
cells. A) Schematic of 
time-point experiment 
B) Analysis of the 
number of ciliated cells 
compared to the amount 
of transfected cells 
treated with B/B 
inhibitor overtime. C) 
Average length of cilia 
over B/B inhibitor time 
course looking at cilia 
markers ARL13B and 
acetylated tubulin.  
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Because non-eukaryotic cells seem to require kinesin-2 motor KIF17, similar experiments 
expressing KIF3A/3B and KIF17 motors in knock-out cell lines were conducted. Adding the B/B 
inhibitor over a time course, the presence and persisting maintenance of a primary cilium would 
suggest that KIF17 does play a role. However, in these double-knockout cells, KIF17 rescue also 
did not produce any cilia (Fig. A4A-B). Moreover, treating cells with the B/B inhibitor yielded the 
same results between KIF17 over- and endogenously-expressed cells, and cilium length 
additionally followed the same trend (Fig. A4C-D). Taken together, this suggests that KIF17 does 
not play an important role and at least is not sufficient for cilia formation 
and maintenance.  
 
 
A.3.3 Ciliary disassembly mechanism still outstanding 
To begin to understand the mechanism of cilia disassembly, we 
utilized the iKIF3A/iKIF3B expression and inhibition in double knock-
Figure A4. KIF17 
is not sufficient to 
make or maintain 
a primary cilium. 
A) In double 
knockout cells, 
only KIF3A/KIF3B 





ce of top: knock 
down cells rescued 
with KIF3A/3B, 
bottom: rescued 
with KIF17. C) 
Percent of ciliated 
cells in double 
knockout cells 
expressing i3A/i3B 
with and without 
KIF17. D) Average 
length of cilia in 
double knockout 
cells expressing 
i3A/i3B with and 
without KIF17 over 
a time course of 
KIF3A/KIF4B 
inhibition with 
B/B.  These 
experiments were 
performed by 
Martin Engelke.  
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out cells to instigate cilium disassmbly and then tested the effect of small molecules that modify 
the microtubules. In seeing how cilium disassembly was impacted by different drug treatments, 
we could make comparisons and inferences into the mechanism of disassembly at the microtubule 
level. As before, the percentage of ciliated cells along with the intensity of ciliary markers 
ARL13B (green) and acetylated tubulin (purple) staining were quantified to monitor the 
disassembly process (Fig. A5A-C, left column).  
The first small molecule we tested was paclitaxel (taxol). Discovered through a 
collaboration between the US Department of Agriculture and the National Cancer Institute, this 
compound, originally extracted from the Pacific yew, blocks cancer cell growth by stopping cell 
division (Wani 1971; Schiff and Horwitz 1980; Arnal and Wade 1995; Horwitz 2019). Indeed, it 
stops non-cancer cell division by binding to microtubules in the mitotic spindle, halting 
chromosomal separation. Adding taxol to microtubules stabilizes the polymers such that they do 
not undergo dynamic instability. In our double-knockout cells, we noticed that adding taxol had. 
no effect on the percentage of cells with primary cilia (Fig. A5A, blue columns). When cilium 
disassembly was induced by addition of B/B inhibitor, taxol seemed to be a partial rescue because 
more cilia remained when taxol was supplemented with B/B inhibitor (Fig. A5A, purple columns). 
Looking at the intensities of ARL13B and acetylated tubulin, it seems that the longer the cell has 
been treated with taxol, the intensity of acetylated tubulin increases (Fig. A5A, right). As such, we 
find that taxol can slow down ciliary disassembly, likely by stabilizing microtubules.  
Next, we looked at the impacts of nocodazole upon ciliary disassembly (Fig. A5B). When 
bound to soluble tubulin dimers, nocodazole inhibits polymerization because it binds along the β-
tubulin interface and it thereby results in the depolymerization of microtubules. As such, we 
expected that adding nocodazole to our double-knockout cells would accelerate ciliary 
disassembly. However, the addition of nocodazole did not accelerate ciliary disassembly driven 
by the inhibtion of KIF4A/KIF3B/KAP (Fig. A5B, green columns). Looking at ARL13B and 
acetylated tubulin intensities within the cilia, we also did not observe an appreciable difference 
upon nocodazole treatment (Fig. A5B, right graph). These data suggest that inhibiting 
polymerization does not facilitate ciliary disassembly.  
Lastly, we were curious if altering acetylated tubulin levels would impact ciliary 
maintenance. Tubulin acetylation is often a marker for stable microtubules (Cambray-Deakin et 
al. 1987, Janke et al. 2017) and antibodies raised against acetylated microtubules are a visual 
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marker for the primary cilium in cells. As such, we wanted to find out if promoting acetylation 
would impact cilia dynamics, so we treated our double-knockout cells with tubacin, a small 
molecule that inhibits deacetylase activity of HDAC6 (Namdar et al. 2010) Surprisingly, we found 
that tubacin treatment alone (yellow) resulted in ciliary disassembly but that the ciliary 
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disassembly induced by inhibition of KIF3A/KIF3B was not affected by the tubacin treatment 
Figure A5. Cilia on drugs.  NIH-3T3 double knockout cells were transfected with 
iKIF3A/iKIF3B-mCherry and treated with small molecules B/B with and without A) taxol, 
B) nocodozol, or C) tubacin. Left column) Cells were then permeabilized and fixed for 
immunofluorescence - DNA (DAPI-280), ciliary marker ARL13B (Rb-488), and 
acetylated tubulin (Ms-680). Middle column) We measured the amount of ciliated cells as 
a percentage of the total transfected (bars showing the mean of four different transfections), 
and Right column) the intensity of signal ARL13 and acetylated tubulin in the cilia 
(measured by line tracing the cilia in ImageJ and subtracting background signal in each 
channel, bars showing the mean intensity for the n-number of cells imaged from the four 
transfection experiments).  
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(Fig. A5C, left graph). The effects of tubacin in this experiment are unclear, however, as the 
expected increase in acetylated tubulin staining was not observed (Fig. A5C, right graph).  
From all these experiments, it’s safe to say that the mechanism of ciliary disassembly 




A.4.1 KIF3A/KIF3B is responsible for soluble tubulin entering cilia by IFT 
We engineered an inhibitable version of the heterotrimeric KIF3A/KIF3B/KAP kinesin-2 
motor that allows for specific inhibition of this motor and thus identifying its role in primary cilia. 
We observed a rapid block to IFT upon inhibition of the inhibitable motor in primary cilia. Without 
the B/B inhibitor, we found that IFT88 moves processively along the length of the cilium and 
anterograde and retrograde directions as expected (Williams et al. 2014; Ye, Nager, and Nachury 
2018). Addition of the B/B inhibitor resulted in a rapid block of IFT within two minutes, and 
disassembly of the cilia overtime. When trying to rescue with KIF17, cilia are not able to form 
suggesting that this motor is not sufficient to make or maintain primary cilia. Taken together, our 
findings show that kinesin-2 motors KIF3A/KIF3B are critical for cilia formation in mammalian 
cells.   
The most dramatic effect of i3A/i3B inhibition is a rapid block to new IFT trains entering 
the cilium. One possibility is that the B/B inhibitor crosslinks and stops i3A/i3B/KPA motors once 
they are activated by cargo binding at the base of the cilium. It is also possible that B/B inhibitor 
crosslinks the motor domains of soluble and autoinhibited kinesin-2 motors, thereby depleting the 
pool of active kinesin-2 that can be recruited to the IFT trains at the base of the cilium. These 
possibilities are not mutually exclusive, given that IFT trains are assembled at the basal body 
(Wingfield et al. 2017). Unlike most organelles, the ciliary membrane is continuous with the 
plasma membrane, rather than being a contained organelle like a mitochondria or vacuole. 
However, the base of the cilia has a transition zone that serves as a permeable barrier (Verhey, 
Dishinger, and Kee 2011). So far, there is no evidence of protein synthesis within a cilia and as 
such any protein within this organelle must be transported there and pass through the transition 
zone. Small proteins (<40 kDa) can diffuse through and some proteins have a cilia localization 
sequence, but most ciliary proteins are carried through the transition zone by the BBSome on IFT 
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trains (Nakayama and Katoh 2018). In Chlamydomonas, ɑ-tubulin can enter the cilia by diffusion, 
but also as IFT cargo. During ciliary growth, IFT concentrates soluble tubulin in the cilia, therefore 
promoting microtubule growth (Craft et al. 2015). Additionally, kinesin-2 tails, particularly 
KIF3A, can bind soluble tubulin, preferentially for a-tubulin isotypes (Girotra et al. 2017). 
Interaction between kinesin tail domains and tubulin has also been documented for kinesin-1 and 
the N-terminal tail of kinesin-14, both promote microtubule stability which mediate microtubule 
gliding in cells (Karabay and Walker 1999; Seeger and Rice 2010). As such, inhibiting 
KIF3A/KIF3B could prevent soluble tubulin entering the cilia. 
 
A.4.2 Ciliary disassembly corresponds to lack of IFT 
After kinesin-2 was inhibited, thus blocking IFT, there was a rapid decrease in the number 
of ciliated cells. Within six hours of kinesin-2 inhibition, there was nearly a complete loss of cilia. 
As such, the assembly and maintenance of cilia depend on protein transport mediated by IFT. 
Without functional IFT, the ciliary structure does not form and cannot be retained. Surprisingly, 
the average cilium length of the remaining cilia decreased only slowly and moderately over the 
time course of kinesin-2 inhibition. It could also be the case that the lack of soluble tubulin in the 
cilia also prevents any rescue of axoneme microtubules, the tubulin either a part of the IFT trains, 
or carried by KIF3A/3B.  
Our findings link functional IFT to cilia maintenance, and thus suggests some mechanisms 
for ciliary disassembly. Without KIF3A/3B, there is a progressive shortening of the cilia over time, 
caused by a decrease in IFT-mediated tubulin delivery. Without enough soluble tubulin near the 
tips of cilia, the rate of disassembly overcomes the rate of assembly and as such the ciliary 
microtubules begin to depolymerize. This so called “balance point” model of microtubule and 
ciliary maintenance has been mathematically simulated based on microtubule turnover and 
experimentally observed in Chlamydomonas flagellum, and suggests a simple steady-state model 
for regulating the cilia that’s length dependent (Wallace F. Marshall et al. 2005; W. F. Marshall 
and Rosenbaum 2001). When we treated the cells with Ciliobrevin D, a dynein inhibitor, we saw 
that both anterograde and retrograde IFT stops within five minutes, but primary cilium remained 
(Engelke et al. 2018). This further supports our model that IFT-mediated transport of tubulin into 
the cilia is critical for maintenance.   
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However, there are other models of cilia disassembly, including mitogenic signals resulting 
in tip shedding (Phua et al. 2019), or the loss of microtubule stability (Mirvis, Stearns, and Nelson 
2018). To try and see if ciliary disassembly relies on the latter, we treated cells with a combination 
of KIF3A/3B inhibitor and small molecules that alter tubulin stability: taxol, nocodazole, and 
tubacin. Unsurprisingly, taxol was able to rescue the effects of the B/B inhibitor, suggesting that 
ciliary disassembly could be driven by increasing microtubule instability. This is supported by our 
finding that nocodazole treatment and B/B inhibitors have additive effects. However, we observed 
that adding tubacin, an HDAC inhibitor, proved to be fairly toxic to the cells and resulted in a 
drastic reduction in cilia. This seems counterintuitive to previous studies identifying acetylation to 
be important for cilia structure (Pitaval et al. 2017; L’Hernault and Rosenbaum 1985a, 1983; Ran 
et al. 2015; L’Hernault and Rosenbaum 1985b). It could be possible that other modifications, like 
tyrosination, glycylation, and polyglutamylation are also critical for proper cilia formation (Rocha 
et al. 2014; Wloga et al. 2009; Gadadhar et al. 2017; Kubo et al. 2015), and more work needs to 
be done looking at the role of post-translational modifications in the context of cilia disassembly.  
 
A.5 Materials and Methods 
Plasmids. KIFi3A/KIFi3B were generated as described in (Engelke et al. 2018).  
 
Immunohistochemistry. Parental NIH-3T3 Flp-In cells (Thermo Fisher Scientific; RRID: 
CVCL_U422) and derived Kif3a-/-;Kif3b-/- cells were cultured in D-MEM (Gibco) with 10% 
Fetal Clone III (HyClone) and GluteMAX (Gibco) at 37°C and 5% CO2. See (Engelke et al. 2018) 
for CRISPR/Cas9-mediated genome editing. Both cell lines were transfected using Lipofectamine 
2000 (Life Technologies) according to the manufacturer’s protocol. Double knockout cells (Kif3a-
/-;Kif3b-/-) were generated by sequentially engineering the Kif3a and Kif3b gene loci.  Double 
knockout cells transiently expressing kinesin motors were fixed with 4% formaldehyde in PBS, 
treated with 50 mM NH4Cl in PBS to quench unreacted formaldehyde and permeabilized with 
0.2% Triton X-100 in PBS. Subsequently, cells were blocked in blocking solution (0.2% fish skin 
gelatin in PBS). Primary and secondary antibodies were applied in blocking solution at room 
temperature for 1 h each. Cells were incubated 3x for 5 min in blocking solution to remove 
unbound antibodies. Antibodies used: polyclonal antibodies reacting with ARL13B (1:1000, 
 115 
Protein Tech Group, 17711-1-AP), IFT88 (1:500, Protein Tech Group, 13967-1-AP), and 
monoclonal antibodies reacting with ARL13B (1:200, NeuroMAB, 73-287), acetylated tubulin 
(1:10.000, Sigma, T6793), KIF3A (K2.4, 1:300, Abcam, ab24626), and polyglutamylated tubulin 
(1:1000, Adipogen Life Sciences, GT335). Nuclei were stained with 10.9 mM40,6-diamidino-2-
phenylindole (DAPI) and cover glasses were mounted in ProlongGold (Life Technologies).  
 
Microscopy. Images were collected on an inverted epifluorescence microscope (Nikon TE2000E) 
equipped with a 60x, 1.40 numerical aperture (NA) oil-immersion objective and a 1.5x tube lens 
on a Photometrics CoolSnapHQ camera driven by NIS-Elements (Nikon) software. Images of 
KIF3A-mNG in cilia were captured by a Nikon A1 confocal system with 603 oil immersion 
objective (NA 1.40) on a high sensitivity GaAsP detector. To measure IFT88-mNG or i3A-mNG 
content of cilia, a region of interest (ROI) was drawn around the cilium shaft (identified by 
ARL13B) and the base of the cilium in ImageJ (NIH) and the average fluorescence intensity in the 
cilium shaft and at the cilium base was measured and the population average was calculated using 
Excel (and plotted in Prism). 
 
Ciliogenesis rescue and disassembly assays. To assess the effect of B/B inhibitor on ciliogenesis, 
cells were seeded on cover glasses and 12 h later, the culture medium was switched to 1% Fetal 
Clone III (serum-starvation). Vehicle (0.1% ethanol final) or 50 nM B/B homodimerizer 
(Clonetech, 635060) was added followed by the transfection complexes. Two days later the cells 
were fixed and stained. To assess the effect of B/B inhibitor or Ciliobrevin D on fully-formed cilia, 
cells were seeded on cover glasses and serum-starved and transfected 12 h later. Two days later, 
vehicle (0.1% ethanol final) or 50 nM B/B homodimerizer or 30 mM Ciliobrevin D (Sigma, 
250401) was added for the indicated times and cells were fixed and stained. Image analysis was 
performed using ImageJ (NIH). Cells expressing mCherry, or mCherry- and mNeonGreen-tagged 
inhibitable motors were selected and analyzed for the presence of a cilium, as judged by an 
ARL13B-positive filament that was R 10 pixel (R1.1 mm). We noted that cells that express low 
levels of the KIF3B and KIF3A constructs had the highest probability to generate cilia. Thus cells 
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Appendix B: Beam shift and accessible data improve cryoEM data 
collection and processing 
B.1 Forward 
This section describes the recent developments in the field of cryo electron microscopy (cryoEM) 
and our contributions to testing data collection and processing pipelines. Here we find that using 
beam-tilt increases the throughput of data collection at the cost of having to correct for aberrations 
at the data processing stage, this work published in (Cash et al. 2020). Additionally, this section 
will discuss the accessibility and future of cryoEM data processing, showing some ongoing work 
on cryoEDU, a cryoEM/ET education platform, in collaboration with the Herzik lab at UCSD, and 
Single Particle LLC. Accessible cryoEM data and education are critical as techniques make the 
technology more accessible, with some discussion and commentary published in (Kearns 2020).  
B.2 Introduction 
 Cryogenic electron microscopy (cryoEM) allows for determining the three-dimensional 
shape and structure of biomacromolecules, like proteins and nucleic acids. By embedding 
biological samples in ice in native conditions, dynamics and conformational changes can be 
determined, two things that are difficult to see using other structural biology techniques like x-ray 
crystallography. The Nobel Prize in Chemistry in 2017 was awarded to Jacques Dubochet, Richard 
Henderson, and Joachim Frank for developing cryoEM (Henderson and Unwin 1975; Saxton and 
Frank 1977; Dubochet et al. 1988). Since their foundational establishments in the field, technical 
advances on numerous fronts, including direct electron detectors, which increases the amount of 
information collected per image, and algorithm developments allowing for motion-correction 
during imaging, have made data collection and processing go to higher resolution, thus being able 
to see structures in high detail (Campbell et al. 2012; Bai et al. 2013; Li et al. 2013). In addition, 
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automated data collection strategies and software for image analysis streamline many methods in 
cryoEM (Suloway et al. 2005; Grant et al. 2018; Scheres 2012; Punjani et al. 2017; Tegunov and 
Cramer 2019). As such, the combination of Nobel hype and technical advances has made cryoEM 
a go-to method for structural analysis. 
 To obtain a high-resolution structure using cryoEM, the sample of interest must first be 
applied to a small grid, which has a mesh made of conductive material and covered with a support 
film. The grid is usually polarized first such that the particles stick to the grid. Excess sample is 
blotted away from the grid to make sure the ice is thin when it’s plunged into a bath of cryogen. 
Next, the grid is clipped such that the mechanical auto-loader in the microscope can pick it up and 
place it on the stage for imaging. Because the microscope contains a system of lenses and 
condensers, electrons shot out from the electron gun (at various voltages depending on the type of 
microscope) at the top of a column are directed towards the sample to produce an image that the 
direct electron detector can see. Data is collected in the form of short movies, and then aligned into 
a single image. From there, particles are picked and fed into various data processing software to 
determine the 3D map and build the atomic model. 
In order to increase the throughput from cryo-EM instruments, many laboratories and 
facilities have begun using beam-image shift for data collection (Cheng et al. 2018). Using this 
approach, instead of moving the stage to each position on the cryo-EM grid, a process that requires 
precise movement, the beam is moved in conjunction with image adjustments. Without long 
waiting times of moving the stage, tilting the beam leads to a dramatic increase in the number of 
exposures per hour. As such, it is now routine to use beam-tilt to collect 100-300 exposures 
whereas previously it was only possible to collect 40-50 per hour. This throughput will continue 
to increase with the advent of direct detectors with faster frame rates, leading to hundreds of 
exposures per hour.  
Even though users can collect two to three times the amount of data using beam-image 
shift, they must overcome an additional aberration induced by the beam-image shift: beam tilt 
(Glaeser et al. 2011). When using beam-image shift for collecting exposures, the resulting image 
will have both axial and off-axis beam tilt (or coma), aberrations that will dampen high-resolution 
(<3Å) information in the micrographs (Glaeser et al. 2011). Beam tilt aberrations can be corrected 
computationally for high-resolution structures, starting with the atomic-resolution structure of 
bacteriorhodopsin from 2D crystals (Henderson et al. 1986). Since its use 40 years ago, recent 
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advances in single-particle cryo-EM have led to the incorporation of beam tilt correction into 
software packages such as RELION (Zivanov et al. 2018; Zivanov, Nakane, and Scheres 2020; 
Herzik, Wu, and Lander 2017; Wu, Lander, and Herzik, 2020) which has lead to the widespread 
adoption of beam tilt correction in cryoEM data processing.  
 Even though beam-image shift data collection in combination with aberration correction 
has been implemented for datasets at 300 keV(Herzik, Wu, and Lander 2017; Wu, Lander, and 
Herzik, 2020), there is limited experimental data on the correction for beam tilt for data sets 
collected at 200 keV. Beam-image shift would likely induce coma, thus introducing optical 
aberrations and we wanted to determine if it can be overcome computationally. Given that the 
phase error caused by either axial or off-axis beam tilt scales with the wavelength squared (Glaeser 
et al. 2011), using a 200 keV microscope will result in worse phase error than a 300 keV 
microscope from both axial and off-axis beam tilt. In order to test the limits of computational 
correction of microscope aberrations at 200 keV, we collected and analyzed a dataset of aldolase 
using beam-image shift on a Talos-Arctica at 200 kV. Using this dataset, I was able to determine 
a 4.9Å structure of aldolase without aberration corrections. Following iterative rounds of axial 
beam tilt correction and particle polishing, we were able to determine a 2.8Å structure of aldolase. 
This indicates that beam-image shift can be an effective data collection strategy to increase the 
throughput on 200 keV cryo-EM instruments, where microscope aberrations can be corrected 
computationally.   
            By going through the process of data processing, we have also noticed a significant 
educational barrier required of new users. In order to start doing cryoEM, practitioners must 
understand concepts that range from biochemistry to physics of electron microscopes to 
computational image alignment algorithms. Although there are cryoEM workshops currently 
available to tackle such concepts with hands-on training, the limited capacity and intimate format 
results in substantial oversubscription and an inability to train cryoEM neophytes en masse. As 
such, there exists a significant gap in training materials and resources that help users understand, 
analyze, interpret, and validate cryoEM data and structure determination. Towards this end, we 





B.3.1 Binning micrographs by beam-tilt groups 
To increase the speed of data collection on the Talos-Arctica, we utilized beam-image shift 
instead of traditional stage movement. In order to test the impact of beam-image shift on data 
quality, we set up the automated data collection system to target 5x5 holes with beam-image shift 
(Fig. B1A). At medium magnification, we typically focused on the middle hole which was 
followed by beam-image shift with distances up to 5 μm away from the beam center. After 
collecting 2,111 micrographs over 18 hours at ten second exposures, we obtained a large range of 
beam-image shift micrographs that provided a near-continuous distribution across the 10 x 10 μm 
area (Fig. B1B). Interestingly, while many micrographs showed minimal objective astigmatism 
(Fig. B1C), a large percentage of the dataset showed exaggerated objective astigmatism (Fig. 
B1D). 
Following data collection, the aldolase beam-image shift data were analyzed using standard 
single-particle processing.. This involved estimating the contrast transfer function (CTF) using 
CTFFIND4 (Rohou and Grigorieff 2015), which yielded CTF fits to higher than 4Å resolution for 
the majority of the micrographs (Fig. B1E). After selecting particles from class averages exhibiting 
high-resolution features, we performed 3D classification in order to obtain a homogenous 
population of aldolase particles with all four subunits intact (Fig. B1F). Using these selected 
particle coordinates, particles were re-extracted at the full pixel size (0.91 Å/pixel) and subjected 
to 3D refinement in RELION. The refined structure reached a resolution of only 4.9Å (Fig. B1G-
H), which is significantly less than published work of ~3Å (Kim et al. 2018; Herzik, Wu, and 
Lander 2017). This suggested that the aberrations from beam tilt induced by beam-image shift data 
collection are likely limiting the resolution of the final structure.  
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 Fig. B1 Beam-tilt data-
collection strategy and 
single particle analysis 
of aldolase without 
beam-tilt.  A) 
Representative image at 
intermediate 
magnification. Red 
cross, focus area; white 
squares, exposures. The 
scale bar is 5 µm. Each 
exposure was collected 
with image-shift beam 
tilt. B) Overview of 
image-shift values from 
Leginon for the beam-
tilt data set. The units 
shown are µm. C-D) 
Representative 
micrographs with 
minimal C) and obvious 
D) beam-tilt-induced 
objective astigmatism. 
Inset: cropped power 
spectrum. The scale bar 
is 100 nm. E) Histogram 
of CTF resolution limits 
across the data set using 
CTFFIND4. (c) 
Representative 2D class 
averages calculated 
using RELION. The 
scale bar is 200 Å. F) 3D 
classification results for 
selected particles after 
2D classification. 
Dashed boxes indicate 
classes with particles 
used for subsequent 3D 
refinement. G) 
Sharpened 
reconstruction after 3D 
refinement using 
RELION filtered to 4.9 
Å resolution. H) FSC 




B.3.2 Iterative beam-tilt correction improves resolution 
After determining a refined 3D structure of aldolase, we wanted to test whether the beam 
tilt refinement option in RELION 3.0 is capable of overcoming such a large degree of axial beam 
tilt. To use this feature of RELION, the micrographs must be grouped into beam tilt groups. 
Considering the near-continuously changing beam-image shift data collection for the entire 
dataset, beam-image shift values from Leginon were used in order to divide the micrographs into 
groups (Fig. B2A). This involved dividing data into groups of 25 (5x5), 100 (10x10), and 400 
(20x20) based on the amount of beam-image shift in Leginon. For each grouping, the particles 
underwent beam tilt refinement, 3D refinement, and sharpening in RELION in order to determine 
the change in the final resolution of the structure. We saw that grouping into 5x5, 10x10, and 
20x20 groups had a significant increase in the final resolution of 4.1Å, 4.0Å, and 3.8Å, 
respectively (Fig. B2B). This result indicates that the previously determined structure at 4.9Å (Fig. 
B2C) was limited in resolution due to beam tilt aberrations that could be partially overcome by 
grouping the data into beam tilt groups in RELION.  
            For the micrographs divided into 400 groups, the subsequently refined map showed 
improved density features and had a gold standard FSC value of 3.8Å (Fig. B2C-D). This indicates 
that beam tilt refinement improved the resolution of aldolase significantly from 4.9Å to 3.8Å in a 
single step. Further iterations of beam-tilt correction, in addition to Bayesian particle polishing, 
further increased the resolution to a final 2.8 Å map. The final structure at 2.8Å (Fig. B2E-F) 
shows dramatically improved density features compared to the original 4.9Å structure. 
Specifically, the significantly higher resolution provides unambiguous secondary structure tracing 
whereas the 4.9Å structure contained many more ambiguities. This structure demonstrates that 




B.3.3 Making cryoEM 
data processing 
education accessible 
To facilitate the 
adoption of cryoEM/ET 
and to train the next 
generation of structural 
biologists, the NIH has 




Strategy for grouping 
micrographs. 
Micrographs were 
grouped into 25 
groups (5 × 5), 100 
groups (10 × 10) and 
400 groups (20 × 20). 
B) The effect of group 
size on beam-tilt 
refinement and 
subsequent resolution 
estimation for refined 
3D structures. C) 
Sharpened 3D 
reconstruction for 
particles placed into 
400 micrograph 
groups filtered to 3.8 
Å resolution. D) FSC 
curves for 3D 
reconstruction. E) 
Sharpened aldolase 
reconstruction at 2.8 





funded both cryoEM/ET data collection centers in addition to cryoEM/ET curricular grants. In 
order to alleviate the often inhibitory financial burden associated with the acquisition, installation, 
and operation state-of-the-art cryoEM facilities, several NIH-funded cryoEM centers -- the 
National Center for CryoEM Access and Training (NCCAT), the Pacific Northwest Center for 
CryoEM (PNCC), and the Stanford-SLAC CryoEM Center (S2C2) -- were established to provide 
practitioners with free access to both sample screening and data collection instruments under the 
supervision of EM experts. To further support users at these national centers, a series of curricular 
grants (EM-Learning.com, CryoEM 101, CryoEM Principles, and cryoVR) were funded that 
addressed theoretical aspects of cryoEM in addition to practical details for sample preparation. 
Despite these critical investments in cryoEM/ET, there remains a gap in the available 
curricula to data analysis. Even though new users have access to online educational curricula and 
on-site training at national centers, users are frequently overwhelmed and often lost when it comes 
to steps related to data assessment, analysis, and validation. Towards this end, we have started to 
build an educational platform focused on cryoEM/ET data processing, called ‘cryoEDU’, that 
helps users understand, analyze, interpret, and validate cryoEM data and structure determination. 
The cryoEDU platform is built upon three pillars: 1) self-paced online modular curricula; 2) hands-
Fig. B3 Overview of cryoEDU Chapter, Modules, and connection to cloud environment. 
CryoEM/ET data processing is broken down into chapters (blue boxes) that form the basis for 
the online curriculum. For each Chapter and Module, there will be directly relevant modules and 
workflows on the cloud environment to provide learners with a hands-on interactive data 
processing experience.  
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on data analysis in a cloud desktop environment; and 3) community engagement to facilitate 
information exchange related to cryoEM/ET data analysis. Our interactive cloud desktop 
environment will enable hands-on learning for users from all science backgrounds and by 
integrating our curriculum within the existing learning environment, we will help to train users 
better to assess, interpret, and analyze cryoEM/ET datasets.  
We have acquired the domain name cryoEDU.org and have since transferred hosting 
services to the Physics Computing Facility at UCSD for maintenance, server operations, and 
Wordpress support. We have elected to use Wordpress to build out the website infrastructure due 
to the extensive support for teaching and learning-based plugins, general ease of use and design, 
as well as the extensive community support. When users first land on cryoEDU.org they will be 
presented with the mission statement of our curriculum, a preview of the topics covered by our 
learning modules, and a means to register for a user account for the self-paced curriculum. This 
will allow each learner to return to cryoEDU.org at a pace suitable for their learning style. From 
the home page, each Chapter will have a dedicated page with associated Modules, Topics, and 
Assessments that will be easily accessible through a user-intuitive toolbar (Fig. 3). 
 
 
Fig. B4 Example of cryoEDU.org layout for Chapter, Modules, and assessment quiz. Left) 
Landing page for Chapter 2 highlighting the progress bar, modules, and lessons available. 
Right) Example assessment quiz related to identifying ‘good’ vs ‘bad’ 2D class averages. 
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In addition to establishing the formal foundation for data processing, the curricula will also 
draw on real-world data examples to highlight appropriate processing schemes. This coupling to 
computational frameworks will give learners hands-on experience with data in an environment 
amenable to learning why data is processed in a certain way. In practice, this will look like a 
“choose your own adventure” as users go through different processing pathways. To limit the 
computational load, the data will be pre-calculated so learners going through the processing 
pathway will be drawing upon already existing data rather than taking the time and resources to 
recalculate data, much like the “choose your own adventure” book series having a predetermined 
number of pages and outcomes. Moreover, the total number of combinations will be limited by 
implementing “dead ends” of data processing, such as too few particles, incorrect CTF parameters, 
incorrect particle size, etc. where learners will net be able to continue down a processing branch if 
a high-resolution reconstruction cannot be obtained or another pathological outcome would result. 
To provide users with a simulated data processing experience, we selected RELION as the 
initial software package that we will use for precalculation and the cloud desktop environment. 
We selected RELION because it’s the most common software associated with deposited entries in 
the EM Data Bank, is open source, is fairly intensive yet GUI-based, and offers developments in 
cryoET, thus allowing for both single particle analysis in addition to sub-tomogram averaging. 
cryoEM/ET software, along with the pre-calculated data, will all be hosted on a cloud environment, 
thus reliving the computational burden in training users to analyze data, in addition to being able 
to train multiple users at once.  
B.4 Discussion 
B.4.1 Data quality and resolution increase with beam-tilt correction 
The dataset analyzed in this work utilized significant beam-image shift data collection at 
200 keV on a Talos-Arctica. This strategy introduced significant microscope aberrations into the 
raw data and was significant enough to cause objective astigmatism in micrographs due to a large 
amount of beam tilt (Figure 2A, right). During data collection, we did not perform additional 
alignments such as those used to set up parallel illumination. We only corrected objective 
astigmatism and beam-tilt pivot points for automatic focusing. Both of these slight adjustments 
did not alter imaging abnormalities suggesting aberrations came from altering the beam-image 
shift during data collection.  
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 By taking advantage of microscope aberration correction in RELION-3.0+ (Zivanov et al., 
2020) we were able to improve the resolution of aldolase from 4.9Å to 2.8Å. While previous work 
demonstrated that aberration refinement allows for resolution improvements for data at both 300 
keV (Zivanov et al., 2018) and 200 keV (Zivanov et al., 2020; Wu et al.), all datasets analyzed 
were collected on relatively well-aligned instruments. With high-quality starting data, the initial 
reconstructions prior to aberration correction achieved ~3Å (unlike this work which was 4.9Å). 
Moreover, the data collected at 200 keV (Wu et al.; Herzik et al., 2017) used stage position instead 
of beam-image shift, further minimizing microscope aberrations in the dataset. Although, it should 
be noted that the observed difference in resolution between our and previous work could have been 
a result of ice thickness, and grid or sample preparation in addition to beam-image shift corrections. 
Using algorithmic improvements in RELION (Zivanov et al., 2018) in combination with 
Bayesian particle polishing (Zivanov et al., 2019), we were able to improve the resolution of 
aldolase to 2.8Å (Figure 4 & 5). Analysis of the measured beam tilts indicates that there was axial 
beam tilt present on the instrument prior to using beam-image shift (Figure 3E). This confirms that 
the microscope had axial beam tilt prior to data collection, where better microscope alignments 
could have minimized this issue. That said, beam tilt correction not only fixes off-axis coma, but 
also other coma from imperfect alignment. 
 
B.4.2 Quicker collection time means longer data processing time 
The main motivation to utilize beam-image shift for data collection instead of stage 
position is the increased data collection throughput. For the dataset collected here, we were able 
to obtain a 2.4X increase in throughput for beam-image shift when compared with stage position: 
73 movies per hour (beam-image shift) vs. 30 movies per hour (stage position). Considering the 
cost of instrument time, beam-image shift provides 1,752 movies per 24 hour period vs. 720 
movies per 24 hour period for stage position. Indeed, the latest generation of detectors that have 
faster readout stands to triple this throughput for beam-image shift (Alewijnse et al. 2017; 
Bromberg et al. 2020).  
Based on our analysis of aldolase, there is a significant difference between 200 keV vs. 
300 keV beam-image shift data collection (for instances where there is not an optical correction 
on the microscope). At 300 keV, it is possible to use a comparable beam-image shift as that used 
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in this study but instead obtain a structure ~3Å (Zivanov et al. 2018). For this dataset at 300 keV, 
beam-image shift provides high-resolution structures prior to aberration correction. Unlike this 
previous study, our aldolase structure collected using beam-image shift at 200 keV was limited in 
resolution due to aberrations to 4.9Å. In order to correct for the aberrations, significant effort was 
required in order to perform optical grouping and analysis, steps that may be beyond beginning to 
intermediate RELION users.  
With these considerations, we advocate beam-image shift at 200 keV for sample screening. 
This is because we observed high-quality 2D class averages for aldolase despite significant beam 
tilt, information well-suited for sample screening (i.e. changing buffers, sample concentrations, 
etc.). However, this study does indicate that even if a user collected data with significant beam tilt 
from beam-image shift data, software-based aberration correction is possible to <3Å for well-
behaved samples like aldolase.  
 
B.4.3 Accessible education and databases improve the field of cryoEM 
Even though our cryoEM education platform, cryoEDU, has not been officially launched 
yet, we anticipate that many who are new to the field will find it useful. Additionally, we expect 
that it’ll continue to bring the community together to discuss best practices in data processing and 
structure validation. We believe that cryoEDU is within the same vein and shares the same purpose 
as the NIH-funded national cryoEM centers which help users collect data.  
Beyond the increasing accessibility of microscopes and cryoEM educational content, open 
data has been a longstanding tradition within the structural biology community (Kearns 2020). For 
structural biology, the Protein Data Bank (PDB) acts as a preservation steward of structural data 
following OA FAIR principles (Wilkinson et al., 2016). Established in 1971, the PDB is the first 
open access digital data resource among all biology and medicine resources. The PDB focuses on 
biocuration, archive management, data exploration, and outreach, which allows for structural 
biology data to impact basic and applied research in a wide variety of applications (Burley et al., 
2018, 2019). As a database that does more than store data and additionally annotates content, the 
PDB, along with partner databases like the Electron Microscopy DataBase (EMDB) and Electron 
Microscopy Public Image Archive (EMPIAR), provides a priceless resource to not only the field 
of structural biology, but to scientific research as a whole.  
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Expert validation, along with biocuration of the model, structure factors, and atom 
coordinates are all deposited into the PDB. Validation provides objective assessments of structure 
quality, and biocurators validate incoming structures using established parameters and software. 
Biocurators work to verify or correct structure coordinates, confirm chemical consistency of the 
3D coordinates and any bound ligands, and in general make sure that the deposited model checks 
with the experimental data (Burkhardt et al. 2006). There are many challenges along the way 
coming from information validation. Despite the careful measures taken by researchers in 
determining and solving structures, PDB biocurators, and validation metrics, errors still exist. Even 
during a pandemic, where key structures were solved in a hurry, deposited structures generally 
haven’t seen a decline in validation scores during the pandemic, but nevertheless verifying cryoEM 
maps and models remains a challenge.  
Even though model validation is tricky, the structural biology community constantly 
discusses and updates validation statistics to keep up with the rapid changes to the field in terms 
of new technologies and software. For example, Dr. Tristan Croll, a researcher at the University 
of Cambridge, started to look at the then recently released structure of an CoV-2 RNA polymerase 
(Fig. 1D), he realized that part of the model did not fit into the electron density map. Using a 
molecular dynamics-based software, ISOLDE (Croll, 2018), he was able to find that a 31-residue 
stretch model was shifted out of register by nine residues. Doing some more investigative research, 
he proposed that this shift in amino acid registry in the CoV-2 structure likely derived from a 
similar issue in the SARS equivalent (pdb 6nur). Since then, the atomic coordinates have been 
updated under the original ID and have been used for atomic model building (Hillen et al., 2020). 
Since then, a whole Coronavirus Structural Task Force, spearheaded by the Thorn Lab, has created 
a whole pipeline for analyzing CoV-2-related structures.  
Method-specific validation task forces determine which experimental data and metadata 
from data collection should be archived and how these data and the derived models should be 
verified. For example, since 2012, an annual Electron Microscopy Validation Task Force Meeting 
concludes with recommendations to increase the impact of electron microscopy in biology and 
medicine (Henderson et al., 2012) and since then modeling and validation challenges have 
occurred, the most recent one occurring in 2019 (Lawson et al. 2020). Periodic conversations 
between experts in the structure field regarding validation statistics create a culture that supports 
best practices in data curation and accessibility. Combining a myriad of knowledge from software 
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developers, wet lab researchers, and data curators combines perspectives and expertise to drive the 
field of structural biology in useful directions. Additionally, it seems structural biologists are 
willing to adapt to community guidelines, even when they are not mandatory. Being aware that 
mistakes happen in the rush to go from cryoEM models to maps, a call was made to the community 
to deposit raw data to EMPIAR. By sharing raw data, there could be a global effort to re-process 
and re-analyze these data to make sure structures are accurate before biologists and 
bioinformaticians use them, like the recently deposited data of CoV-2 virions (Turoňová et al., 
2020).  
As these improvements advance the cryoEM/ET field, I hope that cyroEDU will serve as 
a platform for continued education and conversation with the community. I very much look 
forward to staying up-to-date and working on this project as we secure funding and publish our 
content online. 
 
B.5 Materials & Methods 
Sample preparation. Pure aldolase isolated from rabbit muscle was purchased as a lyophilized 
powder (Sigma Aldrich, 89933139) and solubilized in 20 mM HEPES (pH 7.5), 50 mM NaCl at 
1.6 mg/ml. Sample as dispensed on freshly plasma cleaned UltrAuFoil R1.2/1.3 300-mesh grids 
(Electron Microscopy Services) and applied to grid in the chamber of a Vitrobot (Thermo Fisher) 
at ~95% relative humidity, 4°C. Sample was blotted for 4 seconds with Whatman No. #1 filter 
paper immediately prior to plunge freezing in liquid ethane cooled by liquid nitrogen.  
Cryo-EM data acquisition and image processing. Proper eucentric height of the specimen was 
determined using Leginon immediately before starting data collection. Parallel illumination of the 
beam was achieved earlier in the week by first adjusting the defocus to bring the objective aperture 
into focus in the front focal plane of the diffraction lens in diffraction mode followed by 
adjustments of beam intensity to minimize the spread of diffraction. Data were acquired using the 
Leginon automated data-acquisition program (Suloway et al. 2005). Image pre-processing (frame 
alignment with MotionCor2 (Zheng et al. 2017) and CTF estimation using CTFFIND4 (Rohou 
and Grigorieff 2015)) were done using the Appion processing environment (Lander et al. 2009) 
for real-time feedback during data collection. Images were collected on a Talos Arctica 
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transmission electron microscope (Thermo Fisher) operating at 200 keV with a gun lens of 6, a 
spot size of 6, 70 μm C2 aperture and 100 μm objective aperture using beam-image shift. Movies 
were collected using a K2 direct electron detector (Gatan Inc.) operating in counting mode at 
45,000x corresponding to a physical pixel size of 0.91 Å/pixel with a 10 sec exposure using 200 
ms per frame. Using an exposure rate of 4.204 e/pix/sec, each movie had a total dose of 
approximately 42 e/Å2 for the 2,111 movies over a defocus 0.8-2 μm.  
 
Pre-processing. Movies were aligned using RELION-3.0 (Zivanov et al. 2018) (3.0-beta-2) motion 
correction with 5 patches in both X & Y directions, a B-Factor of 150Å2 without binning. 
Following motion correction, CTF estimation was performed with CTFFIND4 (Rohou and 
Grigorieff 2015) using exhaustive search for a defocus range of 0.5 to 5.0 μm (0.05 μm step size) 
and an astigmatism search range of 0.5 μm within a resolution range of 6 and 30Å. The 
combination of a large astigmatism search with exhaustive searches led to many over-estimates of 
CTF resolution fits for this dataset. Therefore, in order to remove micrographs automatically, we 
utilized our recently developed MicAssess (Li et al., 2020) program to remove all empty and bad 
micrographs. This removed 685 micrographs, leaving 1,426 micrographs for particle picking. 
Particles were picked from aligned micrographs using crYOLO (Wagner et al. 2019) general 
model PhosaurusNet with an anchor size of 98 x 98 pixels.  
 
Single-particle analysis without aberration correction. For 2D classification, 718,578 particles 
were extracted with an unbinned box size of 300 pixels and subsequently binned to 2.73Å (box 
size 100 pixels). Particles were then subjected to 2D classification into 100 classes using RELION-
3.0.2 (T=2; Iter=25). After selecting particles from the best classes, 275,487 particles underwent 
3D classification into 5 classes using RELION-3.0.2 (T=4; Iter=25) and EMD-8743 (Herzik, Wu, 
and Lander 2017) as a reference model. Following the selection of the best classes, 186,841 
particles were centered and re-extracted at 0.91Å/pixel. This stack was used for 3D refinement to 
obtain a post-processed structure with a resolution of 4.9Å and a B-Factor of -347Å2.  
 
Aberration correction and particle polishing. Particles were grouped into optics groups based on 
beam-image shift values obtained from the Leginon database. In order to group particles into 
discrete optics groups, the entire file of beam-image shift values were divided into 5x5, 10x10, or 
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20x20 groups. The first two beam tilt estimation steps (CtfRefine #1 & #2, Figure 4) used 
RELION-3.0 (3.0-beta-2). Subsequent steps (Bayesian polishing and CtfRefine #3) used 
RELION-3.1 (version 30001). All steps for aberration correction and polishing are described in 
Figure 4. Aberration correction and polishing did not improve resolution more than the final 2.8Å 
aldolase structure. We also tested whether using predicted beam tilts from CtfRefine #1 could 
improve the resolution of a final reconstruction, however, this did not improve dataset resolution 
(data not shown). 
 
Model building and refinement. The coordinates for rabbit aldolase (PDB:  5vy5) were docked into 
each map in PHENIX using phenix.dock_in_map (Adams et al. 2012). Structure refinement and 
model validation were performed using phenix.real_space_refine (Afonine et al. 2018). The same 
docking and refinement parameters were used for each map. To make figures showing map 
density, phenix.map_box was used to restrict the map shown to specific stretches of residues. Root 
mean square deviation (rmsd) values comparing all atoms between structures were calculated 
using a Least Squares Fit in Coot (Emsley et al. 2010). The PyMOL Molecular Graphics System 
(Version 2.1, Schrödinger, LLC) was used to render images showing these structures and 
ChimeraX for rendering the map images (Goddard et al. 2018; Pettersen et al. 2020).  
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